BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer. 2011;11:792-804. [PMID: 21979307 DOI: 10.1038/nrc3139] [Cited by in Crossref: 417] [Cited by in F6Publishing: 398] [Article Influence: 41.7] [Reference Citation Analysis]
Number Citing Articles
1 Chi J, Yang Q, Xie XF, Yang XZ, Zhang MY, Wang HY, Xu GL. Clinical significance and prognostic value of TRIM24 expression in esophageal squamous cell carcinoma. Aging (Albany NY) 2016;8:2204-21. [PMID: 27689360 DOI: 10.18632/aging.101037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
2 Kamal AHM, Fessler MB, Chowdhury SM. Comparative and network-based proteomic analysis of low dose ethanol- and lipopolysaccharide-induced macrophages. PLoS One 2018;13:e0193104. [PMID: 29481576 DOI: 10.1371/journal.pone.0193104] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
3 Damineni S, Balaji SA, Shettar A, Nayanala S, Kumar N, Kruthika BS, Subramanian K, Vijayakumar M, Mukherjee G, Gupta V, Kondaiah P. Expression of tripartite motif-containing protein 28 in primary breast carcinoma predicts metastasis and is involved in the stemness, chemoresistance, and tumor growth. Tumour Biol 2017;39:1010428317695919. [PMID: 28381187 DOI: 10.1177/1010428317695919] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hai J, Zhu CQ, Wang T, Organ SL, Shepherd FA, Tsao MS. TRIM14 is a Putative Tumor Suppressor and Regulator of Innate Immune Response in Non-Small Cell Lung Cancer. Sci Rep 2017;7:39692. [PMID: 28059079 DOI: 10.1038/srep39692] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
5 Ong CA, Shannon NB, Ross-Innes CS, O'Donovan M, Rueda OM, Hu DE, Kettunen MI, Walker CE, Noorani A, Hardwick RH, Caldas C, Brindle K, Fitzgerald RC. Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy. J Natl Cancer Inst 2014;106:dju050. [PMID: 24777112 DOI: 10.1093/jnci/dju050] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
6 Chen BS, Li CW. Constructing an integrated genetic and epigenetic cellular network for whole cellular mechanism using high-throughput next-generation sequencing data. BMC Syst Biol 2016;10:18. [PMID: 26897165 DOI: 10.1186/s12918-016-0256-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
7 Wu YT, Ma SY, Sun WQ, Shen WW, Zhu HT, Zhang Q, Chen HF. TRIM65 Promotes Invasion of Endometrial Stromal Cells by Activating ERK1/2/C-myc Signaling via Ubiquitination of DUSP6. J Clin Endocrinol Metab 2021;106:526-38. [PMID: 33146694 DOI: 10.1210/clinem/dgaa804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Rahmé R, Esnault C, de Thé H. Molecular Targets of Treatment in APL. In: Abla O, Lo Coco F, Sanz MA, editors. Acute Promyelocytic Leukemia. Cham: Springer International Publishing; 2018. pp. 17-27. [DOI: 10.1007/978-3-319-64257-4_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Bu N, Dong Z, Zhang L, Zhu W, Wei F, Zheng S. CircPVT1 Regulates Cell Proliferation, Apoptosis and Glycolysis in Hepatocellular Carcinoma via miR-377/TRIM23 Axis. Cancer Manag Res 2020;12:12945-56. [PMID: 33364841 DOI: 10.2147/CMAR.S280478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Liu Y, Dong Y, Zhao L, Su L, Diao K, Mi X. TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway. Mol Carcinog 2018;57:1792-802. [PMID: 30175868 DOI: 10.1002/mc.22897] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
11 Gong LP, Chen JN, Dong M, Xiao ZD, Feng ZY, Pan YH, Zhang Y, Du Y, Zhang JY, Bi YH, Huang JT, Liang J, Shao CK. Epstein-Barr virus-derived circular RNA LMP2A induces stemness in EBV-associated gastric cancer. EMBO Rep 2020;21:e49689. [PMID: 32790025 DOI: 10.15252/embr.201949689] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
12 Zheng J, Zhang Y, Zhi L, Lv S, Xiao L, Huang X, Huang Y, Qin Q. The novel gene TRIM44L from orange-spotted grouper negatively regulates the interferon response. Fish Shellfish Immunol 2019;92:746-55. [PMID: 31279081 DOI: 10.1016/j.fsi.2019.06.062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
13 Suzuki M, Suzuki T, Watanabe M, Hatakeyama S, Kimura S, Nakazono A, Honma A, Nakamaru Y, Vreugde S, Homma A. Role of intracellular zinc in molecular and cellular function in allergic inflammatory diseases. Allergol Int 2021;70:190-200. [PMID: 33127267 DOI: 10.1016/j.alit.2020.09.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Yu C, Chen S, Guo Y, Sun C. Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway. Theranostics 2018;8:3224-36. [PMID: 29930725 DOI: 10.7150/thno.23259] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 10.7] [Reference Citation Analysis]
15 Ai L, Kim WJ, Alpay M, Tang M, Pardo CE, Hatakeyama S, May WS, Kladde MP, Heldermon CD, Siegel EM, Brown KD. TRIM29 suppresses TWIST1 and invasive breast cancer behavior. Cancer Res 2014;74:4875-87. [PMID: 24950909 DOI: 10.1158/0008-5472.CAN-13-3579] [Cited by in Crossref: 49] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
16 Harbi S, Wang R, Gregory M, Hanson N, Kobylarz K, Ryan K, Deng Y, Lopez P, Chiriboga L, Mignatti P. Infantile Hemangioma Originates From A Dysregulated But Not Fully Transformed Multipotent Stem Cell. Sci Rep 2016;6:35811. [PMID: 27786256 DOI: 10.1038/srep35811] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 3.2] [Reference Citation Analysis]
17 Boyer NP, Monkiewicz C, Menon S, Moy SS, Gupton SL. Mammalian TRIM67 Functions in Brain Development and Behavior. eNeuro 2018;5:ENEURO. [PMID: 29911180 DOI: 10.1523/ENEURO.0186-18.2018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
18 Gushchina LV, Kwiatkowski TA, Bhattacharya S, Weisleder NL. Conserved structural and functional aspects of the tripartite motif gene family point towards therapeutic applications in multiple diseases. Pharmacol Ther 2018;185:12-25. [PMID: 29097306 DOI: 10.1016/j.pharmthera.2017.10.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
19 Hatakeyama S. TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis. Trends in Biochemical Sciences 2017;42:297-311. [DOI: 10.1016/j.tibs.2017.01.002] [Cited by in Crossref: 273] [Cited by in F6Publishing: 240] [Article Influence: 68.3] [Reference Citation Analysis]
20 Ma X, Li D, Gao Y, Liu C. miR-451a Inhibits the Growth and Invasion of Osteosarcoma via Targeting TRIM66. Technol Cancer Res Treat 2019;18:1533033819870209. [PMID: 31434545 DOI: 10.1177/1533033819870209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Lv T, Jiang L, Kong L, Yang J. MicroRNA‑29c‑3p acts as a tumor suppressor gene and inhibits tumor progression in hepatocellular carcinoma by targeting TRIM31. Oncol Rep 2020;43:953-64. [PMID: 32020206 DOI: 10.3892/or.2020.7469] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Masuda Y, Takahashi H, Hatakeyama S. TRIM29 regulates the p63-mediated pathway in cervical cancer cells. Biochim Biophys Acta 2015;1853:2296-305. [PMID: 26071105 DOI: 10.1016/j.bbamcr.2015.05.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
23 Kimura T, Mandell M, Deretic V. Precision autophagy directed by receptor regulators - emerging examples within the TRIM family. J Cell Sci 2016;129:881-91. [PMID: 26906420 DOI: 10.1242/jcs.163758] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 12.8] [Reference Citation Analysis]
24 Grande E, Earl J, Fuentes R, Carrato A. New targeted approaches against the ubiquitin–proteasome system in gastrointestinal malignancies. Expert Review of Anticancer Therapy 2014;12:457-67. [DOI: 10.1586/era.12.26] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
25 He T, Cui J, Wu Y, Sun X, Chen N. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway. Life Sci 2019;235:116799. [PMID: 31472144 DOI: 10.1016/j.lfs.2019.116799] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
26 Aierken G, Seyiti A, Alifu M, Kuerban G. Knockdown of Tripartite-59 (TRIM59) Inhibits Cellular Proliferation and Migration in Human Cervical Cancer Cells. Oncol Res 2017;25:381-8. [PMID: 27662486 DOI: 10.3727/096504016X14741511303522] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
27 Huang Y, Zhang J, Liu J, Hu Y, Ni S, Yang Y, Yu Y, Huang X, Qin Q. Fish TRIM35 negatively regulates the interferon signaling pathway in response to grouper nodavirus infection. Fish Shellfish Immunol 2017;69:142-52. [PMID: 28823982 DOI: 10.1016/j.fsi.2017.08.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
28 Banerjee A, Guttridge DC. Mechanisms for maintaining muscle. Curr Opin Support Palliat Care 2012;6:451-6. [PMID: 23108340 DOI: 10.1097/SPC.0b013e328359b681] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
29 Zhu X, Wu Y, Miao X, Li C, Yin H, Yang S, Lu X, Liu Y, Chen Y, Shen R, Chen X, He S. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma. Tumour Biol 2016;37:14615-28. [PMID: 27619678 DOI: 10.1007/s13277-016-5316-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
30 Ma Y, Wei Z, Bast RC, Wang Z, Li Y, Gao M, Liu Y, Wang X, Guo C, Zhang L, Wang X. Downregulation of TRIM27 expression inhibits the proliferation of ovarian cancer cells in vitro and in vivo. Lab Invest 2016;96:37-48. [DOI: 10.1038/labinvest.2015.132] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
31 Shang M, Weng L, Xu G, Wu S, Liu B, Yin X, Mao A, Zou X, Wang Z. TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adenocarcinoma. J Cell Physiol 2021;236:6868-83. [PMID: 33629745 DOI: 10.1002/jcp.30346] [Reference Citation Analysis]
32 Zhang L, Afolabi LO, Wan X, Li Y, Chen L. Emerging Roles of Tripartite Motif-Containing Family Proteins (TRIMs) in Eliminating Misfolded Proteins. Front Cell Dev Biol 2020;8:802. [PMID: 32984318 DOI: 10.3389/fcell.2020.00802] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
33 Yao Y, Liu Z, Guo H, Huang S, Zhong M, Deng J, Xiong J. Elevated TRIM23 expression predicts poor prognosis in Chinese gastric cancer. Pathol Res Pract 2018;214:2062-8. [PMID: 30477642 DOI: 10.1016/j.prp.2018.10.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
34 Sang Y, Li Y, Song L, Alvarez AA, Zhang W, Lv D, Tang J, Liu F, Chang Z, Hatakeyama S, Hu B, Cheng SY, Feng H. TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3. Cancer Res 2018;78:1792-804. [PMID: 29386185 DOI: 10.1158/0008-5472.CAN-17-2774] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 7.3] [Reference Citation Analysis]
35 Zhang DQ, Zhou CK, Chen SZ, Yang Y, Shi BK. Identification of hub genes and pathways associated with bladder cancer based on co-expression network analysis. Oncol Lett 2017;14:1115-22. [PMID: 28693282 DOI: 10.3892/ol.2017.6267] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
36 Jin Z, Li H, Hong X, Ying G, Lu X, Zhuang L, Wu S. TRIM14 promotes colorectal cancer cell migration and invasion through the SPHK1/STAT3 pathway. Cancer Cell Int. 2018;18:202. [PMID: 30555277 DOI: 10.1186/s12935-018-0701-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
37 Wang P, Benhenda S, Wu H, Lallemand-Breitenbach V, Zhen T, Jollivet F, Peres L, Li Y, Chen SJ, Chen Z, de Thé H, Meng G. RING tetramerization is required for nuclear body biogenesis and PML sumoylation. Nat Commun 2018;9:1277. [PMID: 29599493 DOI: 10.1038/s41467-018-03498-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 12.0] [Reference Citation Analysis]
38 Li S, Zhao J, Shang D, Kass DJ, Zhao Y. Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment. JCI Insight 2018;3:120362. [PMID: 29769446 DOI: 10.1172/jci.insight.120362] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
39 Sato T, Takahashi H, Hatakeyama S, Iguchi A, Ariga T. The TRIM-FLMN protein TRIM45 directly interacts with RACK1 and negatively regulates PKC-mediated signaling pathway. Oncogene 2015;34:1280-91. [PMID: 24681954 DOI: 10.1038/onc.2014.68] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
40 Zhou L, Deng ZZ, Li HY, Jiang N, Wei ZS, Hong MF, Chen XD, Wang JH, Zhang MX, Shi YH, Lu ZQ, Huang XM. TRIM31 promotes glioma proliferation and invasion through activating NF-κB pathway. Onco Targets Ther 2019;12:2289-97. [PMID: 30988633 DOI: 10.2147/OTT.S183625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
41 Wang E, Kawaoka S, Roe JS, Shi J, Hohmann AF, Xu Y, Bhagwat AS, Suzuki Y, Kinney JB, Vakoc CR. The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer. Elife 2015;4:e06377. [PMID: 25919951 DOI: 10.7554/eLife.06377] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
42 Yu T, Gan S, Zhu Q, Dai D, Li N, Wang H, Chen X, Hou D, Wang Y, Pan Q, Xu J, Zhang X, Liu J, Pei S, Peng C, Wu P, Romano S, Mao C, Huang M, Zhu X, Shen K, Qin J, Xiao Y. Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24. Nat Commun 2019;10:4353. [PMID: 31554795 DOI: 10.1038/s41467-019-12384-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 23.0] [Reference Citation Analysis]
43 Zhang R, Li SW, Liu L, Yang J, Huang G, Sang Y. TRIM11 facilitates chemoresistance in nasopharyngeal carcinoma by activating the β-catenin/ABCC9 axis via p62-selective autophagic degradation of Daple. Oncogenesis 2020;9:45. [PMID: 32382014 DOI: 10.1038/s41389-020-0229-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
44 Wang Y, Singh AR, Zhao Y, Du T, Huang Y, Wan X, Mukhopadhyay D, Wang Y, Wang N, Zhang P. TRIM28 regulates sprouting angiogenesis through VEGFR-DLL4-Notch signaling circuit. FASEB J 2020;34:14710-24. [PMID: 32918765 DOI: 10.1096/fj.202000186RRR] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Massagué J. TGFβ signalling in context. Nat Rev Mol Cell Biol 2012;13:616-30. [PMID: 22992590 DOI: 10.1038/nrm3434] [Cited by in Crossref: 1815] [Cited by in F6Publishing: 1614] [Article Influence: 201.7] [Reference Citation Analysis]
46 Chakraborty A, Diefenbacher ME, Mylona A, Kassel O, Behrens A. The E3 ubiquitin ligase Trim7 mediates c-Jun/AP-1 activation by Ras signalling. Nat Commun 2015;6:6782. [PMID: 25851810 DOI: 10.1038/ncomms7782] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
47 Watanabe M, Hatakeyama S. TRIM proteins and diseases. J Biochem. 2017;161:135-144. [PMID: 28069866 DOI: 10.1093/jb/mvw087] [Cited by in Crossref: 22] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
48 Gao B, Baudis M. Signatures of Discriminative Copy Number Aberrations in 31 Cancer Subtypes. Front Genet 2021;12:654887. [PMID: 34054918 DOI: 10.3389/fgene.2021.654887] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Hao L, Leng J, Xiao R, Kingsley T, Li X, Tu Z, Yang X, Deng X, Xiong M, Xiong J, Zhang Q. Bioinformatics analysis of the prognostic value of Tripartite Motif 28 in breast cancer. Oncol Lett 2017;13:2670-8. [PMID: 28454449 DOI: 10.3892/ol.2017.5764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
50 Liu L, Zhao E, Li C, Huang L, Xiao L, Cheng L, Huang X, Song Y, Xu D. TRIM28, a new molecular marker predicting metastasis and survival in early-stage non-small cell lung cancer. Cancer Epidemiol 2013;37:71-8. [PMID: 22959342 DOI: 10.1016/j.canep.2012.08.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
51 Han Y, Tan Y, Zhao Y, Zhang Y, He X, Yu L, Jiang H, Lu H, Tian H. TRIM23 overexpression is a poor prognostic factor and contributes to carcinogenesis in colorectal cancer. J Cell Mol Med 2020;24:5491-500. [PMID: 32227572 DOI: 10.1111/jcmm.15203] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
52 Tong X, Mu P, Zhang Y, Zhao J, Wang X. TRIM59, amplified in ovarian cancer, promotes tumorigenesis through the MKP3/ERK pathway. J Cell Physiol 2020;235:8236-45. [PMID: 31951023 DOI: 10.1002/jcp.29478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Fu X, Luo L, Yi R, Ding B, Wang C, Zhang W, Wang X, Yang Y, Chen C, Fei X, Hu D, Xu R. Transcriptome profiling in Eid1-KO mice brain shows that Eid1 links cell proliferation in the brain. Gene 2019;717:143998. [PMID: 31381951 DOI: 10.1016/j.gene.2019.143998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Chen G, Kong J, Tucker-Burden C, Anand M, Rong Y, Rahman F, Moreno CS, Van Meir EG, Hadjipanayis CG, Brat DJ. Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma. Cancer Res 2014;74:4536-48. [PMID: 24947043 DOI: 10.1158/0008-5472.CAN-13-3703] [Cited by in Crossref: 54] [Cited by in F6Publishing: 33] [Article Influence: 7.7] [Reference Citation Analysis]
55 Gong F, Chiu LY, Miller KM. Acetylation Reader Proteins: Linking Acetylation Signaling to Genome Maintenance and Cancer. PLoS Genet 2016;12:e1006272. [PMID: 27631103 DOI: 10.1371/journal.pgen.1006272] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 12.6] [Reference Citation Analysis]
56 Jovčevska I, Zupanec N, Kočevar N, Cesselli D, Podergajs N, Stokin CL, Myers MP, Muyldermans S, Ghassabeh GH, Motaln H, Ruaro ME, Bourkoula E, Turnšek TL, Komel R. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers. PLoS One 2014;9:e113688. [PMID: 25419715 DOI: 10.1371/journal.pone.0113688] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
57 Lv S, Zhang Y, Zheng J, Huang X, Huang Y, Qin Q. Negative regulation of the interferon response by finTRIM82 in the orange spotted grouper. Fish Shellfish Immunol 2019;88:391-402. [PMID: 30853655 DOI: 10.1016/j.fsi.2019.03.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
58 Zoumpoulidou G, Broceño C, Li H, Bird D, Thomas G, Mittnacht S. Role of the Tripartite Motif Protein 27 in Cancer Development. JNCI: Journal of the National Cancer Institute 2012;104:941-52. [DOI: 10.1093/jnci/djs224] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
59 Hattlmann CJ, Kelly JN, Barr SD. TRIM22: A Diverse and Dynamic Antiviral Protein. Mol Biol Int 2012;2012:153415. [PMID: 22649727 DOI: 10.1155/2012/153415] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
60 Valletti A, Marzano F, Pesole G, Sbisà E, Tullo A. Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer? Int J Mol Sci 2019;20:E1776. [PMID: 30974870 DOI: 10.3390/ijms20071776] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
61 Watanabe M, Takahashi H, Saeki Y, Ozaki T, Itoh S, Suzuki M, Mizushima W, Tanaka K, Hatakeyama S. The E3 ubiquitin ligase TRIM23 regulates adipocyte differentiation via stabilization of the adipogenic activator PPARγ. Elife 2015;4:e05615. [PMID: 25905670 DOI: 10.7554/eLife.05615] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 5.7] [Reference Citation Analysis]
62 Kokate SB, Dixit P, Das L, Rath S, Roy AD, Poirah I, Chakraborty D, Rout N, Singh SP, Bhattacharyya A. Acetylation-mediated Siah2 stabilization enhances PHD3 degradation in Helicobacter pylori-infected gastric epithelial cancer cells. FASEB J 2018;32:5378-89. [PMID: 29688807 DOI: 10.1096/fj.201701344RRR] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
63 Yu C, Ding Z, Liang H, Zhang B, Chen X. The Roles of TIF1γ in Cancer. Front Oncol 2019;9:979. [PMID: 31632911 DOI: 10.3389/fonc.2019.00979] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
64 Liang Q, Tang C, Tang M, Zhang Q, Gao Y, Ge Z. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4. J Exp Clin Cancer Res 2019;38:159. [PMID: 30979374 DOI: 10.1186/s13046-019-1143-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
65 Ong CA, Shapiro J, Nason KS, Davison JM, Liu X, Ross-Innes C, O'Donovan M, Dinjens WN, Biermann K, Shannon N, Worster S, Schulz LK, Luketich JD, Wijnhoven BP, Hardwick RH, Fitzgerald RC. Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma. J Clin Oncol 2013;31:1576-82. [PMID: 23509313 DOI: 10.1200/JCO.2012.45.9636] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]
66 Kotobuki Y, Tonomura K, Fujimoto M. Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis. Immunol Med 2021;44:23-9. [PMID: 32649853 DOI: 10.1080/25785826.2020.1791402] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Meroni G. Genomics and evolution of the TRIM gene family. Adv Exp Med Biol 2012;770:1-9. [PMID: 23630996 DOI: 10.1007/978-1-4614-5398-7_1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
68 Miao C, Liang C, Li P, Liu B, Qin C, Yuan H, Liu Y, Zhu J, Cui Y, Xu A, Wang S, Su S, Li J, Shao P, Wang Z. TRIM37 orchestrates renal cell carcinoma progression via histone H2A ubiquitination-dependent manner. J Exp Clin Cancer Res 2021;40:195. [PMID: 34130705 DOI: 10.1186/s13046-021-01980-0] [Reference Citation Analysis]
69 Sulistio YA, Heese K. The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease. Mol Neurobiol 2016;53:905-31. [PMID: 25561438 DOI: 10.1007/s12035-014-9063-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 8.8] [Reference Citation Analysis]
70 Chrétien M, Legouge C, Martin RZ, Hammann A, Trad M, Aucagne R, Largeot A, Bastie J, Delva L, Quéré R. Trim33/Tif1γ is involved in late stages of granulomonopoiesis in mice. Experimental Hematology 2016;44:727-739.e6. [DOI: 10.1016/j.exphem.2016.04.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
71 Zhu Y, Zhao L, Shi K, Huang Z, Chen B. TRIM24 promotes hepatocellular carcinoma progression via AMPK signaling. Exp Cell Res 2018;367:274-81. [PMID: 29627320 DOI: 10.1016/j.yexcr.2018.04.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
72 Yamaki Y, Kagawa H, Hatta T, Natsume T, Kawahara H. The C-terminal cytoplasmic tail of hedgehog receptor Patched1 is a platform for E3 ubiquitin ligase complexes. Mol Cell Biochem 2016;414:1-12. [PMID: 26885983 DOI: 10.1007/s11010-015-2643-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
73 Tan G, Yi Z, Song H, Xu F, Li F, Aliyari R, Zhang H, Du P, Ding Y, Niu J, Wang X, Su L, Qin FX, Cheng G. Type-I-IFN-Stimulated Gene TRIM5γ Inhibits HBV Replication by Promoting HBx Degradation. Cell Rep 2019;29:3551-3563.e3. [PMID: 31825835 DOI: 10.1016/j.celrep.2019.11.041] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
74 Fristrup N, Birkenkamp-Demtröder K, Reinert T, Sanchez-Carbayo M, Segersten U, Malmström PU, Palou J, Alvarez-Múgica M, Pan CC, Ulhøi BP, Borre M, Ørntoft TF, Dyrskjøt L. Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer. Am J Pathol 2013;182:339-49. [PMID: 23201130 DOI: 10.1016/j.ajpath.2012.10.017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
75 Sun Y, Ho GH, Koong HN, Sivaramakrishnan G, Ang WT, Koh QM, Lin VC. Down-regulation of tripartite-motif containing 22 expression in breast cancer is associated with a lack of p53-mediated induction. Biochem Biophys Res Commun 2013;441:600-6. [PMID: 24183724 DOI: 10.1016/j.bbrc.2013.10.110] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
76 Yu B, Luo F, Sun B, Liu W, Shi Q, Cheng SY, Chen C, Chen G, Li Y, Feng H. KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer. Adv Sci (Weinh) 2021;:e2100014. [PMID: 34392614 DOI: 10.1002/advs.202100014] [Reference Citation Analysis]
77 Feng KH, Sun M, Iketani S, Holmes EC, Parrish CR. Comparing the functions of equine and canine influenza H3N8 virus PA-X proteins: Suppression of reporter gene expression and modulation of global host gene expression. Virology 2016;496:138-46. [PMID: 27314620 DOI: 10.1016/j.virol.2016.06.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
78 Wallenhammar A, Anandapadamanaban M, Lemak A, Mirabello C, Lundström P, Wallner B, Sunnerhagen M. Solution NMR structure of the TRIM21 B-box2 and identification of residues involved in its interaction with the RING domain. PLoS One 2017;12:e0181551. [PMID: 28753623 DOI: 10.1371/journal.pone.0181551] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
79 Godec A, Jayasinghe R, Chrisinger JSA, Prudner B, Ball T, Wang Y, Srihari D, Kaushal M, Dietz H, Zhang X, Pekmezci M, Dahiya S, Tao Y, Luo J, Van Tine BA, Ding L, Gutmann DH, Hirbe AC. Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1. Neurooncol Adv 2020;2:i75-84. [PMID: 32642734 DOI: 10.1093/noajnl/vdz026] [Reference Citation Analysis]
80 Peng R, Zhang PF, Zhang C, Huang XY, Ding YB, Deng B, Bai DS, Xu YP. Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling. Cancer Med 2018;7:796-808. [PMID: 29446253 DOI: 10.1002/cam4.1313] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
81 Han ZJ, Feng YH, Gu BH, Li YM, Chen H. The post-translational modification, SUMOylation, and cancer (Review). Int J Oncol 2018;52:1081-94. [PMID: 29484374 DOI: 10.3892/ijo.2018.4280] [Cited by in Crossref: 25] [Cited by in F6Publishing: 45] [Article Influence: 8.3] [Reference Citation Analysis]
82 Selva-O'Callaghan A, Ros J, Gil-Vila A, Vila-Pijoan G, Trallero-Araguás E, Pinal-Fernandez I. Malignancy and myositis, from molecular mimicry to tumor infiltrating lymphocytes. Neuromuscul Disord 2019;29:819-25. [PMID: 31635909 DOI: 10.1016/j.nmd.2019.09.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Hatakeyama S. Early evidence for the role of TRIM29 in multiple cancer models. Expert Opinion on Therapeutic Targets 2016;20:767-70. [DOI: 10.1517/14728222.2016.1148687] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
84 Gan Y, Cao C, Li A, Song H, Kuang G, Ma B, Zhang Q, Zhang Q. Silencing of the TRIM58 Gene by Aberrant Promoter Methylation is Associated with a Poor Patient Outcome and Promotes Cell Proliferation and Migration in Clear Cell Renal Cell Carcinoma. Front Mol Biosci 2021;8:655126. [PMID: 33816562 DOI: 10.3389/fmolb.2021.655126] [Reference Citation Analysis]
85 Shen W, Jin Z, Tong X, Wang H, Zhuang L, Lu X, Wu S. TRIM14 promotes cell proliferation and inhibits apoptosis by suppressing PTEN in colorectal cancer. Cancer Manag Res 2019;11:5725-35. [PMID: 31296997 DOI: 10.2147/CMAR.S210782] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
86 Liu Y, Wang G, Jiang X, Li W, Zhai C, Shang F, Chen S, Zhao Z, Yu W. TRIM67 inhibits tumor proliferation and metastasis by mediating MAPK11 in Colorectal Cancer. J Cancer 2020;11:6025-37. [PMID: 32922543 DOI: 10.7150/jca.47538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Pauletto E, Eickhoff N, Padrão NA, Blattner C, Zwart W. TRIMming Down Hormone-Driven Cancers: The Biological Impact of TRIM Proteins on Tumor Development, Progression and Prognostication. Cells 2021;10:1517. [PMID: 34208621 DOI: 10.3390/cells10061517] [Reference Citation Analysis]
88 Chen G, Zhou T, Liu Y, Yu Z. Combinatory inhibition of TRIM65 and MDM2 in lung cancer cells. Biochemical and Biophysical Research Communications 2018;506:698-702. [DOI: 10.1016/j.bbrc.2018.10.130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
89 Ma Y, Dai HY, Zhang F, Zhao D. TRIM66 expression in non-small cell lung cancer: A new predictor of prognosis. Cancer Biomark 2017;20:309-15. [PMID: 28946563 DOI: 10.3233/CBM-170207] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
90 Al-Maleki AR, Loke MF, Lui SY, Ramli NSK, Khosravi Y, Ng CG, Venkatraman G, Goh KL, Ho B, Vadivelu J. Helicobacter pylori outer inflammatory protein A (OipA) suppresses apoptosis of AGS gastric cells in vitro. Cell Microbiol 2017;19. [PMID: 28776327 DOI: 10.1111/cmi.12771] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
91 Santos J, Gil J. TRIM28/KAP1 regulates senescence. Immunol Lett 2014;162:281-9. [PMID: 25160591 DOI: 10.1016/j.imlet.2014.08.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
92 Ferri F, Parcelier A, Petit V, Gallouet AS, Lewandowski D, Dalloz M, van den Heuvel A, Kolovos P, Soler E, Squadrito ML, De Palma M, Davidson I, Rousselet G, Romeo PH. TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation. Nat Commun 2015;6:8900. [PMID: 26592194 DOI: 10.1038/ncomms9900] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
93 Liu Y, Li J, Wang F, Mao F, Zhang Y, Zhang Y, Yu Z. The first molluscan TRIM9 is involved in the negative regulation of NF-κB activity in the Hong Kong oyster, Crassostrea hongkongensis. Fish & Shellfish Immunology 2016;56:106-10. [DOI: 10.1016/j.fsi.2016.06.057] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
94 Yang W, Liu L, Li C, Luo N, Chen R, Li L, Yu F, Cheng Z. TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway. Cell Death Dis 2018;9:908. [PMID: 30185771 DOI: 10.1038/s41419-018-0881-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
95 Heras G, Namuduri AV, Traini L, Shevchenko G, Falk A, Bergström Lind S, Jia M, Tian G, Gastaldello S. Muscle RING-finger protein-1 (MuRF1) functions and cellular localization are regulated by SUMO1 post-translational modification. J Mol Cell Biol 2019;11:356-70. [PMID: 29868881 DOI: 10.1093/jmcb/mjy036] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
96 Masuda Y, Takahashi H, Sato S, Tomomori-Sato C, Saraf A, Washburn MP, Florens L, Conaway RC, Conaway JW, Hatakeyama S. TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin. Nat Commun 2015;6:7299. [PMID: 26095369 DOI: 10.1038/ncomms8299] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
97 Wang H, Fang ZL, Zhang GH, Ma X. TRIM44, a crucial target of miR-410, functions as a potential oncogene in osteosarcoma. Onco Targets Ther 2018;11:3637-47. [PMID: 29950867 DOI: 10.2147/OTT.S163163] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
98 Avraham A, Cho SS, Uhlmann R, Polak ML, Sandbank J, Karni T, Pappo I, Halperin R, Vaknin Z, Sella A, Sukumar S, Evron E. Tissue specific DNA methylation in normal human breast epithelium and in breast cancer. PLoS One 2014;9:e91805. [PMID: 24651077 DOI: 10.1371/journal.pone.0091805] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
99 McCann JJ, Vasilevskaya IA, Poudel Neupane N, Shafi AA, McNair C, Dylgjeri E, Mandigo AC, Schiewer MJ, Schrecengost RS, Gallagher P, Stanek TJ, McMahon SB, Berman-Booty LD, Ostrander WF Jr, Knudsen KE. USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA Repair. Cancer Res 2020;80:430-43. [PMID: 31740444 DOI: 10.1158/0008-5472.CAN-19-1033] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
100 Wang Y, Zhou Z, Wang X, Zhang X, Chen Y, Bai J, Di W. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression. Int J Biol Sci. 2018;14:2073-2082. [PMID: 30585270 DOI: 10.7150/ijbs.28757] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
101 Wynne C, Lazzari E, Smith S, McCarthy EM, Ní Gabhann J, Kallal LE, Higgs R, Greco A, Cryan SA, Biron CA, Jefferies CA. TRIM68 negatively regulates IFN-β production by degrading TRK fused gene, a novel driver of IFN-β downstream of anti-viral detection systems. PLoS One 2014;9:e101503. [PMID: 24999993 DOI: 10.1371/journal.pone.0101503] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
102 Zhao L, Li W, Luo X, Sheng S. The multifaceted roles of nucleophagy in cancer development and therapy. Cell Biol Int 2021;45:246-57. [PMID: 33219602 DOI: 10.1002/cbin.11504] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, Roth B, Cheng T, Tran M, Lee IL, Melquist J, Bondaruk J, Majewski T, Zhang S, Pretzsch S, Baggerly K, Siefker-Radtke A, Czerniak B, Dinney CP, McConkey DJ. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 2014;25:152-65. [PMID: 24525232 DOI: 10.1016/j.ccr.2014.01.009] [Cited by in Crossref: 895] [Cited by in F6Publishing: 733] [Article Influence: 127.9] [Reference Citation Analysis]
104 Xu Y, Wu G, Zhang J, Li J, Ruan N, Zhang J, Zhang Z, Chen Y, Zhang Q, Xia Q. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro. BioMed Research International 2020;2020:1-18. [DOI: 10.1155/2020/8409239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
105 Yan Y, Yang N, Cheng HH, Song J, Qu L. Genome-wide identification of copy number variations between two chicken lines that differ in genetic resistance to Marek's disease. BMC Genomics 2015;16:843. [PMID: 26492869 DOI: 10.1186/s12864-015-2080-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
106 Kawabata H, Azuma K, Ikeda K, Sugitani I, Kinowaki K, Fujii T, Osaki A, Saeki T, Horie-Inoue K, Inoue S. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling. Int J Mol Sci 2017;18:E1931. [PMID: 28885545 DOI: 10.3390/ijms18091931] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
107 Motegi SI, Sekiguchi A, Ikeuchi H, Sakairi T, Ogawa H, Fujii T, Sohda M, Yajima T, Ida S, Takayasu Y, Shimoda Y, Hiromura K, Saeki H, Shirabe K, Chikamatsu K, Yokoo H, Oyama T, Ishikawa O. Clinical features of anti-transcription intermediary factor 1γ (TIF1γ)-positive dermatomyositis with internal malignancy and investigation of the involvement of TIF1γ expression in tumors in the pathogenesis of cancer-associated dermatomyositis. J Dermatol 2020;47:1395-402. [PMID: 32734678 DOI: 10.1111/1346-8138.15526] [Reference Citation Analysis]
108 Cui X, Lin Z, Chen Y, Mao X, Ni W, Liu J, Zhou H, Shan X, Chen L, Lv J, Shen Z, Duan C, Hu B, Ni R. Upregulated TRIM32 correlates with enhanced cell proliferation and poor prognosis in hepatocellular carcinoma. Mol Cell Biochem 2016;421:127-37. [DOI: 10.1007/s11010-016-2793-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
109 Bell JL, Malyukova A, Kavallaris M, Marshall GM, Cheung BB. TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localization. Cell Cycle 2013;12:889-98. [PMID: 23422002 DOI: 10.4161/cc.23825] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
110 Wang W, Huang Y, Yu Y, Yang Y, Xu M, Chen X, Ni S, Qin Q, Huang X. Fish TRIM39 regulates cell cycle progression and exerts its antiviral function against iridovirus and nodavirus. Fish Shellfish Immunol 2016;50:1-10. [PMID: 26784918 DOI: 10.1016/j.fsi.2016.01.016] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 8.4] [Reference Citation Analysis]
111 Chen Y, Sun J, Ma J. Proliferation and invasion of ovarian cancer cells are suppressed by knockdown of TRIM11. Oncol Lett 2017;14:2125-30. [PMID: 28781653 DOI: 10.3892/ol.2017.6432] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
112 Kashimoto K, Komatsu S, Ichikawa D, Arita T, Konishi H, Nagata H, Takeshita H, Nishimura Y, Hirajima S, Kawaguchi T, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E. Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma. Cancer Sci 2012;103:2021-6. [PMID: 22862969 DOI: 10.1111/j.1349-7006.2012.02407.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
113 Czerwińska P, Mazurek S, Wiznerowicz M. The complexity of TRIM28 contribution to cancer. J Biomed Sci 2017;24:63. [PMID: 28851455 DOI: 10.1186/s12929-017-0374-4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 38] [Article Influence: 13.0] [Reference Citation Analysis]
114 Fusco C, Micale L, Egorov M, Monti M, D'Addetta EV, Augello B, Cozzolino F, Calcagnì A, Fontana A, Polishchuk RS, Didelot G, Reymond A, Pucci P, Merla G. The E3-ubiquitin ligase TRIM50 interacts with HDAC6 and p62, and promotes the sequestration and clearance of ubiquitinated proteins into the aggresome. PLoS One 2012;7:e40440. [PMID: 22792322 DOI: 10.1371/journal.pone.0040440] [Cited by in Crossref: 63] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
115 Marzano F, Caratozzolo MF, Pesole G, Sbisà E, Tullo A. TRIM Proteins in Colorectal Cancer: TRIM8 as a Promising Therapeutic Target in Chemo Resistance. Biomedicines 2021;9:241. [PMID: 33673719 DOI: 10.3390/biomedicines9030241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Wang W, Zhou Z, Xiang L, Lv M, Ni T, Deng J, Wang H, Masatara S, Zhou Y, Liu Y. CHIP-mediated ubiquitination of Galectin-1 predicts colorectal cancer prognosis. Int J Biol Sci 2020;16:719-29. [PMID: 32025218 DOI: 10.7150/ijbs.41125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
117 Kori M, Gov E, Arga KY. Molecular signatures of ovarian diseases: Insights from network medicine perspective. Syst Biol Reprod Med 2016;62:266-82. [PMID: 27341345 DOI: 10.1080/19396368.2016.1197982] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
118 Esposito D, Koliopoulos MG, Rittinger K. Structural determinants of TRIM protein function. Biochemical Society Transactions 2017;45:183-91. [DOI: 10.1042/bst20160325] [Cited by in Crossref: 72] [Cited by in F6Publishing: 32] [Article Influence: 18.0] [Reference Citation Analysis]
119 Deschênes-Simard X, Lessard F, Gaumont-Leclerc MF, Bardeesy N, Ferbeyre G. Cellular senescence and protein degradation: breaking down cancer. Cell Cycle 2014;13:1840-58. [PMID: 24866342 DOI: 10.4161/cc.29335] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
120 Lazzari E, Meroni G. TRIM32 ubiquitin E3 ligase, one enzyme for several pathologies: From muscular dystrophy to tumours. Int J Biochem Cell Biol 2016;79:469-77. [PMID: 27458054 DOI: 10.1016/j.biocel.2016.07.023] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
121 Flegel C, Manteniotis S, Osthold S, Hatt H, Gisselmann G. Expression profile of ectopic olfactory receptors determined by deep sequencing. PLoS One 2013;8:e55368. [PMID: 23405139 DOI: 10.1371/journal.pone.0055368] [Cited by in Crossref: 163] [Cited by in F6Publishing: 137] [Article Influence: 20.4] [Reference Citation Analysis]
122 Cui Z, Cao W, Li J, Song X, Mao L, Chen W. TRIM24 overexpression is common in locally advanced head and neck squamous cell carcinoma and correlates with aggressive malignant phenotypes. PLoS One 2013;8:e63887. [PMID: 23717505 DOI: 10.1371/journal.pone.0063887] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
123 Shi M, Cho H, Inn KS, Yang A, Zhao Z, Liang Q, Versteeg GA, Amini-Bavil-Olyaee S, Wong LY, Zlokovic BV, Park HS, García-Sastre A, Jung JU. Negative regulation of NF-κB activity by brain-specific TRIpartite Motif protein 9. Nat Commun 2014;5:4820. [PMID: 25190485 DOI: 10.1038/ncomms5820] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
124 Zhang Y, Wu H, Lv F, Xiao R. MG53: Biological Function and Potential as a Therapeutic Target. Mol Pharmacol 2017;92:211-8. [DOI: 10.1124/mol.117.108241] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
125 Broughton KM, Khieu T, Nguyen N, Rosa M, Mohsin S, Quijada P, Wang BJ, Echeagaray OH, Kubli DA, Kim T, Firouzi F, Monsanto MM, Gude NA, Adamson RM, Dembitsky WP, Davis ME, Sussman MA. Cardiac interstitial tetraploid cells can escape replicative senescence in rodents but not large mammals. Commun Biol 2019;2:205. [PMID: 31231694 DOI: 10.1038/s42003-019-0453-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
126 Ebner P, Versteeg GA, Ikeda F. Ubiquitin enzymes in the regulation of immune responses. Crit Rev Biochem Mol Biol 2017;52:425-60. [PMID: 28524749 DOI: 10.1080/10409238.2017.1325829] [Cited by in Crossref: 66] [Cited by in F6Publishing: 53] [Article Influence: 16.5] [Reference Citation Analysis]
127 Fujimura T, Inoue S, Urano T, Takayama K, Yamada Y, Ikeda K, Obinata D, Ashikari D, Takahashi S, Homma Y. Increased Expression of Tripartite Motif (TRIM) 47 Is a Negative Prognostic Predictor in Human Prostate Cancer. Clin Genitourin Cancer 2016;14:298-303. [PMID: 26873435 DOI: 10.1016/j.clgc.2016.01.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
128 Gao B, Xu W, Wang Y, Zhong L, Xiong S. Induction of TRIM22 by IFN-γ Involves JAK and PC-PLC/PKC, but Not MAPKs and pI3K/Akt/mTOR Pathways. J Interferon Cytokine Res 2013;33:578-87. [PMID: 23659673 DOI: 10.1089/jir.2012.0170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
129 Appikonda S, Thakkar KN, Barton MC. Regulation of gene expression in human cancers by TRIM24. Drug Discov Today Technol 2016;19:57-63. [PMID: 27769359 DOI: 10.1016/j.ddtec.2016.05.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
130 Sato J, Azuma K, Kinowaki K, Ikeda K, Ogura T, Takazawa Y, Kawabata H, Kitagawa M, Inoue S. Combined A20 and tripartite motif-containing 44 as poor prognostic factors for breast cancer patients of the Japanese population. Pathol Int 2021;71:60-9. [PMID: 33159706 DOI: 10.1111/pin.13047] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Gelato KA, Shaikhibrahim Z, Ocker M, Haendler B. Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs. Expert Opinion on Therapeutic Targets 2016;20:783-99. [DOI: 10.1517/14728222.2016.1134490] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
132 Zhang L, Zhang B, Wei M, Xu Z, Kong W, Deng K, Xu X, Zhang L, Ζhao X, Yan L. TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis. Int J Oncol 2020;56:1225-39. [PMID: 32319602 DOI: 10.3892/ijo.2020.5004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
133 Li YH, Zhong M, Zang HL, Tian XF. The E3 ligase for metastasis associated 1 protein, TRIM25, is targeted by microRNA-873 in hepatocellular carcinoma. Exp Cell Res 2018;368:37-41. [PMID: 29654742 DOI: 10.1016/j.yexcr.2018.04.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
134 Palmer WS, Poncet-Montange G, Liu G, Petrocchi A, Reyna N, Subramanian G, Theroff J, Yau A, Kost-Alimova M, Bardenhagen JP, Leo E, Shepard HE, Tieu TN, Shi X, Zhan Y, Zhao S, Barton MC, Draetta G, Toniatti C, Jones P, Geck Do M, Andersen JN. Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor. J Med Chem 2016;59:1440-54. [PMID: 26061247 DOI: 10.1021/acs.jmedchem.5b00405] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 13.7] [Reference Citation Analysis]
135 Qi ZX, Cai JJ, Chen LC, Yue Q, Gong Y, Yao Y, Mao Y. TRIM28 as an independent prognostic marker plays critical roles in glioma progression. J Neurooncol 2016;126:19-26. [PMID: 26476730 DOI: 10.1007/s11060-015-1897-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
136 Huang B, Pei HZ, Chang HW, Baek SH. The E3 ubiquitin ligase Trim13 regulates Nur77 stability via casein kinase 2α. Sci Rep 2018;8:13895. [PMID: 30224829 DOI: 10.1038/s41598-018-32391-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
137 Kim PY, Rahmanto AS, Tan O, Norris MD, Haber M, Marshall GM, Cheung BB. TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cells. Apoptosis 2013;18:639-51. [PMID: 23404198 DOI: 10.1007/s10495-013-0813-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
138 Höflmayer D, Fraune C, Hube-Magg C, Simon R, Schroeder C, Büscheck F, Möller K, Dum D, Weidemann S, Wittmer C, Schlomm T, Huland H, Heinzer H, Graefen M, Haese A, Sauter G, Burandt E, Clauditz TS, Steurer S, Minner S, Wilczak W, Polonski A. Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate Cancer. Appl Immunohistochem Mol Morphol 2021;29:e29-38. [PMID: 33491944 DOI: 10.1097/PAI.0000000000000901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Kim PY, Tan O, Liu B, Trahair T, Liu T, Haber M, Norris MD, Marshall GM, Cheung BB. High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients. Cancer Letters 2016;374:315-23. [DOI: 10.1016/j.canlet.2016.02.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
140 Chen L, Muñoz-Antonia T, Cress WD. Trim28 contributes to EMT via regulation of E-cadherin and N-cadherin in lung cancer cell lines. PLoS One 2014;9:e101040. [PMID: 24983967 DOI: 10.1371/journal.pone.0101040] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
141 Diao W, Zhu C, Guo Q, Cao Y, Song Y, Feng H, Li J, Xue X, Lu P. Tripartite motif‑containing 14 regulates cell proliferation and apoptosis in cervical cancer via the Akt signaling pathway. Mol Med Rep 2020;22:5145-54. [PMID: 33174608 DOI: 10.3892/mmr.2020.11634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Li F, Sun Q, Liu K, Zhang L, Lin N, You K, Liu M, Kon N, Tian F, Mao Z, Li T, Tong T, Qin J, Gu W, Li D, Zhao W. OTUD5 cooperates with TRIM25 in transcriptional regulation and tumor progression via deubiquitination activity. Nat Commun 2020;11:4184. [PMID: 32826889 DOI: 10.1038/s41467-020-17926-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
143 Chen L, Li M, Li Q, Xu M, Zhong W. Knockdown of TRIM47 inhibits glioma cell proliferation, migration and invasion through the inactivation of Wnt/β-catenin pathway. Mol Cell Probes 2020;53:101623. [PMID: 32603762 DOI: 10.1016/j.mcp.2020.101623] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
144 Chen Y, Ding Y, Wang LM. Tripartite motif-containing 35 (TRIM35) is up-regulated in UUO-induced renal fibrosis animal model. Histol Histopathol 2020;35:1427-35. [PMID: 32955098 DOI: 10.14670/HH-18-255] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Ali H, Mano M, Braga L, Naseem A, Marini B, Vu DM, Collesi C, Meroni G, Lusic M, Giacca M. Cellular TRIM33 restrains HIV-1 infection by targeting viral integrase for proteasomal degradation. Nat Commun 2019;10:926. [PMID: 30804369 DOI: 10.1038/s41467-019-08810-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
146 Lan Q, Tan X, He P, Li W, Tian S, Dong W. TRIM11 Promotes Proliferation, Migration, Invasion and EMT of Gastric Cancer by Activating β-Catenin Signaling. Onco Targets Ther 2021;14:1429-40. [PMID: 33658804 DOI: 10.2147/OTT.S289922] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Liu B, Li NL, Shen Y, Bao X, Fabrizio T, Elbahesh H, Webby RJ, Li K. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis. J Virol 2016;90:4369-82. [PMID: 26889027 DOI: 10.1128/JVI.03172-15] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 9.6] [Reference Citation Analysis]
148 Li L, Shao MY, Zou SC, Xiao ZF, Chen ZC. MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44. J Neurooncol 2019;141:19-30. [PMID: 30539341 DOI: 10.1007/s11060-018-2973-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
149 Si W, Zhou J, Zhao Y, Zheng J, Cui L. SET7/9 promotes multiple malignant processes in breast cancer development via RUNX2 activation and is negatively regulated by TRIM21. Cell Death Dis 2020;11:151. [PMID: 32102992 DOI: 10.1038/s41419-020-2350-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
150 Kanda M, Sugimoto H, Kodera Y. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World J Gastroenterol. 2015;21:10584-10597. [PMID: 26457018 DOI: 10.3748/wjg.v21.i37.10584] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
151 Liu Y, Raheja R, Yeh N, Ciznadija D, Pedraza AM, Ozawa T, Hukkelhoven E, Erdjument-Bromage H, Tempst P, Gauthier NP, Brennan C, Holland EC, Koff A. TRIM3, a tumor suppressor linked to regulation of p21(Waf1/Cip1.). Oncogene 2014;33:308-15. [PMID: 23318451 DOI: 10.1038/onc.2012.596] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
152 Kung CP, Khaku S, Jennis M, Zhou Y, Murphy ME. Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes. Mol Cancer Res 2015;13:250-62. [PMID: 25256710 DOI: 10.1158/1541-7786.MCR-14-0385] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
153 Alpi AF, Chaugule V, Walden H. Mechanism and disease association of E2-conjugating enzymes: lessons from UBE2T and UBE2L3. Biochem J 2016;473:3401-19. [PMID: 27729585 DOI: 10.1042/BCJ20160028] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
154 Martín-Vicente M, Medrano LM, Resino S, García-Sastre A, Martínez I. TRIM25 in the Regulation of the Antiviral Innate Immunity. Front Immunol 2017;8:1187. [PMID: 29018447 DOI: 10.3389/fimmu.2017.01187] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 12.5] [Reference Citation Analysis]
155 Zhou W, Zhang Y, Zhong C, Hu J, Hu H, Zhou D, Cao M. Decreased expression of TRIM21 indicates unfavorable outcome and promotes cell growth in breast cancer. Cancer Manag Res 2018;10:3687-96. [PMID: 30288100 DOI: 10.2147/CMAR.S175470] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 7.7] [Reference Citation Analysis]
156 Li Z, Wang L, Yue H, Whitson BA, Haggard E, Xu X, Ma J. MG53, A Tissue Repair Protein with Broad Applications in Regenerative Medicine. Cells 2021;10:122. [PMID: 33440658 DOI: 10.3390/cells10010122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
157 Bien SA, Su YR, Conti DV, Harrison TA, Qu C, Guo X, Lu Y, Albanes D, Auer PL, Banbury BL, Berndt SI, Bézieau S, Brenner H, Buchanan DD, Caan BJ, Campbell PT, Carlson CS, Chan AT, Chang-Claude J, Chen S, Connolly CM, Easton DF, Feskens EJM, Gallinger S, Giles GG, Gunter MJ, Hampe J, Huyghe JR, Hoffmeister M, Hudson TJ, Jacobs EJ, Jenkins MA, Kampman E, Kang HM, Kühn T, Küry S, Lejbkowicz F, Le Marchand L, Milne RL, Li L, Li CI, Lindblom A, Lindor NM, Martín V, McNeil CE, Melas M, Moreno V, Newcomb PA, Offit K, Pharaoh PDP, Potter JD, Qu C, Riboli E, Rennert G, Sala N, Schafmayer C, Scacheri PC, Schmit SL, Severi G, Slattery ML, Smith JD, Trichopoulou A, Tumino R, Ulrich CM, van Duijnhoven FJB, Van Guelpen B, Weinstein SJ, White E, Wolk A, Woods MO, Wu AH, Abecasis GR, Casey G, Nickerson DA, Gruber SB, Hsu L, Zheng W, Peters U. Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer. Hum Genet 2019;138:307-26. [PMID: 30820706 DOI: 10.1007/s00439-019-01989-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
158 Winkle CC, Olsen RH, Kim H, Moy SS, Song J, Gupton SL. Trim9 Deletion Alters the Morphogenesis of Developing and Adult-Born Hippocampal Neurons and Impairs Spatial Learning and Memory. J Neurosci 2016;36:4940-58. [PMID: 27147649 DOI: 10.1523/JNEUROSCI.3876-15.2016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
159 Chen W, Peng R, Sun Y, Liu H, Zhang L, Peng H, Zhang Z. The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathy via the miR‐449a/b/Trim11/Mek signaling pathway. FASEB j 2019;33:11492-506. [DOI: 10.1096/fj.201900522r] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
160 Williams FP, Haubrich K, Perez-Borrajero C, Hennig J. Emerging RNA-binding roles in the TRIM family of ubiquitin ligases. Biol Chem 2019;400:1443-64. [PMID: 31120853 DOI: 10.1515/hsz-2019-0158] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 23.0] [Reference Citation Analysis]
161 Huang F, Xiao H, Sun BL, Yang RG. Characterization of TRIM62 as a RING finger E3 ubiquitin ligase and its subcellular localization. Biochem Biophys Res Commun 2013;432:208-13. [PMID: 23402750 DOI: 10.1016/j.bbrc.2013.02.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
162 Zhao L, Wang Z, Zhang P, Yu X, Su X. Poly r(C) Binding Protein 1 Regulates Posttranscriptional Expression of the Ubiquitin Ligase TRIM56 in Ovarian Cancer: PCBP1 REGULATES TRIM56 IN OVARIAN CANCER. IUBMB Life 2019;71:177-82. [DOI: 10.1002/iub.1948] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
163 VanGenderen C, Harkness TAA, Arnason TG. The role of Anaphase Promoting Complex activation, inhibition and substrates in cancer development and progression. Aging (Albany NY) 2020;12:15818-55. [PMID: 32805721 DOI: 10.18632/aging.103792] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
164 Sinnott R, Winters L, Larson B, Mytsa D, Taus P, Cappell KM, Whitehurst AW. Mechanisms promoting escape from mitotic stress-induced tumor cell death. Cancer Res 2014;74:3857-69. [PMID: 24860162 DOI: 10.1158/0008-5472.CAN-13-3398] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
165 Huang Y, Yang M, Yu Y, Yang Y, Zhou L, Huang X, Qin Q. Grouper TRIM13 exerts negative regulation of antiviral immune response against nodavirus. Fish Shellfish Immunol 2016;55:106-15. [PMID: 27235367 DOI: 10.1016/j.fsi.2016.05.029] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
166 Raheja R, Liu Y, Hukkelhoven E, Yeh N, Koff A. The ability of TRIM3 to induce growth arrest depends on RING-dependent E3 ligase activity. Biochem J 2014;458:537-45. [PMID: 24393003 DOI: 10.1042/BJ20131288] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
167 Herquel B, Ouararhni K, Martianov I, Le Gras S, Ye T, Keime C, Lerouge T, Jost B, Cammas F, Losson R, Davidson I. Trim24-repressed VL30 retrotransposons regulate gene expression by producing noncoding RNA. Nat Struct Mol Biol 2013;20:339-46. [PMID: 23377542 DOI: 10.1038/nsmb.2496] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
168 Zhang HX, Xu ZS, Lin H, Li M, Xia T, Cui K, Wang SY, Li Y, Shu HB, Wang YY. TRIM27 mediates STAT3 activation at retromer-positive structures to promote colitis and colitis-associated carcinogenesis. Nat Commun 2018;9:3441. [PMID: 30143645 DOI: 10.1038/s41467-018-05796-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
169 Ji J, Ding K, Luo T, Zhang X, Chen A, Zhang D, Li G, Thorsen F, Huang B, Li X, Wang J. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα. Cell Death Differ 2021;28:367-81. [PMID: 32814880 DOI: 10.1038/s41418-020-00606-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
170 Edmonds MJ, Carter RJ, Nickson CM, Williams SC, Parsons JL. Ubiquitylation-dependent regulation of NEIL1 by Mule and TRIM26 is required for the cellular DNA damage response. Nucleic Acids Res 2017;45:726-38. [PMID: 27924031 DOI: 10.1093/nar/gkw959] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
171 Pan X, Chen Y, Shen Y, Tantai J. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7. Cell Death Dis 2019;10:429. [PMID: 31160576 DOI: 10.1038/s41419-019-1660-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 18.0] [Reference Citation Analysis]
172 Linossi EM, Nicholson SE. The SOCS box-adapting proteins for ubiquitination and proteasomal degradation. IUBMB Life 2012;64:316-23. [PMID: 22362562 DOI: 10.1002/iub.1011] [Cited by in Crossref: 69] [Cited by in F6Publishing: 52] [Article Influence: 7.7] [Reference Citation Analysis]
173 Kulathu Y, Komander D. Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol 2012;13:508-23. [PMID: 22820888 DOI: 10.1038/nrm3394] [Cited by in Crossref: 438] [Cited by in F6Publishing: 367] [Article Influence: 48.7] [Reference Citation Analysis]
174 Serikawa T, Spanos C, von Hacht A, Budisa N, Rappsilber J, Kurreck J. Comprehensive identification of proteins binding to RNA G-quadruplex motifs in the 5' UTR of tumor-associated mRNAs. Biochimie 2018;144:169-84. [PMID: 29129743 DOI: 10.1016/j.biochi.2017.11.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
175 Chen L, Yang X. TRIM11 cooperates with HSF1 to suppress the anti-tumor effect of proteotoxic stress drugs. Cell Cycle 2019;18:60-8. [PMID: 30563406 DOI: 10.1080/15384101.2018.1558870] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
176 Gao D, Zhou Z, Huang H. miR-30b-3p Inhibits Proliferation and Invasion of Hepatocellular Carcinoma Cells via Suppressing PI3K/Akt Pathway. Front Genet 2019;10:1274. [PMID: 31921311 DOI: 10.3389/fgene.2019.01274] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
177 Yang H, Meng L, Ai D, Hou N, Li H, Shuai X, Peng X. Acetic acid alleviates the inflammatory response and liver injury in septic mice by increasing the expression of TRIM40. Exp Ther Med 2019;17:2789-98. [PMID: 30906467 DOI: 10.3892/etm.2019.7274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
178 Mandell MA, Jain A, Arko-Mensah J, Chauhan S, Kimura T, Dinkins C, Silvestri G, Münch J, Kirchhoff F, Simonsen A, Wei Y, Levine B, Johansen T, Deretic V. TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Dev Cell 2014;30:394-409. [PMID: 25127057 DOI: 10.1016/j.devcel.2014.06.013] [Cited by in Crossref: 197] [Cited by in F6Publishing: 182] [Article Influence: 28.1] [Reference Citation Analysis]
179 Mishima C, Kagara N, Matsui S, Tanei T, Naoi Y, Shimoda M, Shimomura A, Shimazu K, Kim SJ, Noguchi S. Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients. Springerplus 2015;4:635. [PMID: 26543769 DOI: 10.1186/s40064-015-1423-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
180 Xiao Z, Jiang Q, Willette-Brown J, Xi S, Zhu F, Burkett S, Back T, Song NY, Datla M, Sun Z, Goldszmid R, Lin F, Cohoon T, Pike K, Wu X, Schrump DS, Wong KK, Young HA, Trinchieri G, Wiltrout RH, Hu Y. The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas. Cancer Cell 2013;23:527-40. [PMID: 23597566 DOI: 10.1016/j.ccr.2013.03.009] [Cited by in Crossref: 84] [Cited by in F6Publishing: 72] [Article Influence: 10.5] [Reference Citation Analysis]
181 Choi SK, Pandiyan K, Eun JW, Yang X, Hong SH, Nam SW, Jones PA, Liang G, You JS. Epigenetic landscape change analysis during human EMT sheds light on a key EMT mediator TRIM29. Oncotarget 2017;8:98322-35. [PMID: 29228692 DOI: 10.18632/oncotarget.21681] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
182 Chaugule VK, Walden H. Specificity and disease in the ubiquitin system. Biochem Soc Trans 2016;44:212-27. [PMID: 26862208 DOI: 10.1042/BST20150209] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 6.2] [Reference Citation Analysis]
183 Li L, Yu Y, Zhang Z, Guo Y, Yin T, Wu H, Yang M. TRIM47 accelerates aerobic glycolysis and tumor progression through regulating ubiquitination of FBP1 in pancreatic cancer. Pharmacol Res 2021;166:105429. [PMID: 33529753 DOI: 10.1016/j.phrs.2021.105429] [Reference Citation Analysis]
184 Xie W, Zhang Y, Wang B, Hu Y, Zhan B, Wei F, Tang J, Lian J. Tripartite motif containing 24 regulates cell proliferation in colorectal cancer through YAP signaling. Cancer Med 2020;9:6367-76. [PMID: 32677374 DOI: 10.1002/cam4.3310] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
185 Chen W, Zhao K, Miao C, Xu A, Zhang J, Zhu J, Su S, Wang Z. Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells. Onco Targets Ther 2017;10:1503-12. [PMID: 28331343 DOI: 10.2147/OTT.S130139] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
186 Hayashi F, Kasamatsu A, Endo-Sakamoto Y, Eizuka K, Hiroshima K, Kita A, Saito T, Koike K, Tanzawa H, Uzawa K. Increased expression of tripartite motif (TRIM) like 2 promotes tumoral growth in human oral cancer. Biochem Biophys Res Commun 2019;508:1133-8. [PMID: 30554657 DOI: 10.1016/j.bbrc.2018.12.060] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
187 Fitzgerald S, Sheehan KM, O'grady A, Kenny D, O'kennedy R, Kay EW, Kijanka GS. Relationship between epithelial and stromal TRIM28 expression predicts survival in colorectal cancer patients: TRIM28 predicts survival in colorectal cancer. J Gastroenterol Hepatol 2013;28:967-74. [DOI: 10.1111/jgh.12157] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
188 Kondo T, Watanabe M, Hatakeyama S. TRIM59 interacts with ECSIT and negatively regulates NF-κB and IRF-3/7-mediated signal pathways. Biochemical and Biophysical Research Communications 2012;422:501-7. [DOI: 10.1016/j.bbrc.2012.05.028] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
189 Qin B, Zou S, Li K, Wang H, Wei W, Zhang B, Xiao L, Choi HH, Tang Q, Huang D, Liu Q, Pan Q, Meng M, Fang L, Lee MH. CSN6-TRIM21 axis instigates cancer stemness during tumorigenesis. Br J Cancer 2020;122:1673-85. [PMID: 32225170 DOI: 10.1038/s41416-020-0779-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
190 Lee YS, Ko E, Yoon EL, Jung YK, Kim JH, Seo YS, Yim HJ, Kim KH, Kwon SY, Yeon JE, Um SH, Byun KS. Multiplexed Proteomic Approach for Identification of Serum Biomarkers in Hepatocellular Carcinoma Patients with Normal AFP. J Clin Med 2020;9:E323. [PMID: 31979338 DOI: 10.3390/jcm9020323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
191 Li Y, Ma X, Wu W, Chen Z, Meng G. PML Nuclear Body Biogenesis, Carcinogenesis, and Targeted Therapy. Trends Cancer 2020;6:889-906. [PMID: 32527650 DOI: 10.1016/j.trecan.2020.05.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
192 Wang M, Wu J, Zhou E, Chang X, Gan J, Cheng T. Forkhead box o3a suppresses lipopolysaccharide-stimulated proliferation and inflammation in fibroblast-like synoviocytes through regulating tripartite motif-containing protein 3. J Cell Physiol 2019;234:20139-48. [PMID: 30980385 DOI: 10.1002/jcp.28615] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
193 Ichimura T, Taoka M, Shoji I, Kato H, Sato T, Hatakeyama S, Isobe T, Hachiya N. 14-3-3 proteins sequester a pool of soluble TRIM32 ubiquitin ligase to repress autoubiquitylation and cytoplasmic body formation. J Cell Sci 2013;126:2014-26. [PMID: 23444366 DOI: 10.1242/jcs.122069] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
194 Tan Z, Liu X, Yu E, Wang H, Tang L, Wang H, Fu C. Lentivirus-mediated RNA interference of tripartite motif 68 inhibits the proliferation of colorectal cancer cell lines SW1116 and HCT116 in vitro. Oncol Lett 2017;13:2649-55. [PMID: 28454446 DOI: 10.3892/ol.2017.5787] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
195 Gao R, Lv G, Zhang C, Wang X, Chen L. TRIM59 induces epithelial-to-mesenchymal transition and promotes migration and invasion by PI3K/AKT signaling pathway in medulloblastoma. Oncol Lett 2018;15:8253-60. [PMID: 29805559 DOI: 10.3892/ol.2018.8432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
196 Chen Z, Wang Z, Guo W, Zhang Z, Zhao F, Zhao Y, Jia D, Ding J, Wang H, Yao M, He X. TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma. Oncogene 2015;34:3946-56. [PMID: 25263439 DOI: 10.1038/onc.2014.325] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
197 Xie H, Wang Y, Zhu T, Feng S, Yan Z, Zhu Z, Ni J, Ni J, Du R, Zhu J, Ding F, Liu S, Han H, Zhang H, Zhao J, Zhang R, Quan W, Yan X. Serum MG53/TRIM72 Is Associated With the Presence and Severity of Coronary Artery Disease and Acute Myocardial Infarction. Front Physiol 2020;11:617845. [PMID: 33391037 DOI: 10.3389/fphys.2020.617845] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
198 Zhu K, Xie V, Huang S. Epigenetic regulation of cancer stem cell and tumorigenesis. Adv Cancer Res 2020;148:1-26. [PMID: 32723561 DOI: 10.1016/bs.acr.2020.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
199 Liu X, Long Z, Cai H, Yu S, Wu J. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination. Cancer Biol Ther 2020;21:203-12. [PMID: 31747856 DOI: 10.1080/15384047.2019.1679554] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
200 Franch-Expósito S, Esteban-Jurado C, Garre P, Quintanilla I, Duran-Sanchon S, Díaz-Gay M, Bonjoch L, Cuatrecasas M, Samper E, Muñoz J, Ocaña T, Carballal S, López-Cerón M, Castells A, Vila-Casadesús M, Derdak S, Laurie S, Beltran S, Carvajal J, Bujanda L, Ruiz-Ponte C, Camps J, Gironella M, Lozano JJ, Balaguer F, Cubiella J, Caldés T, Castellví-Bel S; EPICOLON consortium. Rare germline copy number variants in colorectal cancer predisposition characterized by exome sequencing analysis. J Genet Genomics 2018;45:41-5. [PMID: 29396139 DOI: 10.1016/j.jgg.2017.12.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
201 Liu J, Zhang C, Wang X, Hu W, Feng Z. Tumor suppressor p53 cross-talks with TRIM family proteins. Genes Dis 2021;8:463-74. [PMID: 34179310 DOI: 10.1016/j.gendis.2020.07.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Li H, Qu L, Zhou R, Wu Y, Zhou S, Zhang Y, Cheng B, Ni J, Huang H, Hou J. TRIM13 inhibits cell migration and invasion in clear-cell renal cell carcinoma. Nutr Cancer 2020;72:1115-24. [PMID: 31762344 DOI: 10.1080/01635581.2019.1675721] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
203 Li Y, Ma C, Zhou T, Liu Y, Sun L, Yu Z. TRIM65 negatively regulates p53 through ubiquitination. Biochem Biophys Res Commun 2016;473:278-82. [PMID: 27012201 DOI: 10.1016/j.bbrc.2016.03.093] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
204 Kim YJ, Jeon Y, Kim T, Lim WC, Ham J, Park YN, Kim TJ, Ko H. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells. Bioorg Med Chem Lett 2017;27:1081-8. [PMID: 28110870 DOI: 10.1016/j.bmcl.2016.12.042] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
205 Caratozzolo MF, Valletti A, Gigante M, Aiello I, Mastropasqua F, Marzano F, Ditonno P, Carrieri G, Simonnet H, D'Erchia AM, Ranieri E, Pesole G, Sbisà E, Tullo A. TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma. Oncotarget 2014;5:7446-57. [PMID: 25277184 DOI: 10.18632/oncotarget.2081] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
206 Tan T, Ko YG, Ma J. Dual function of MG53 in membrane repair and insulin signaling. BMB Rep 2016;49:414-23. [PMID: 27174502 DOI: 10.5483/bmbrep.2016.49.8.079] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
207 Lv D, Li Y, Zhang W, Alvarez AA, Song L, Tang J, Gao WQ, Hu B, Cheng SY, Feng H. TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma. Nat Commun 2017;8:1454. [PMID: 29129908 DOI: 10.1038/s41467-017-01731-w] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 11.8] [Reference Citation Analysis]
208 Nasrullah U, Haeussler K, Biyanee A, Wittig I, Pfeilschifter J, Eberhardt W. Identification of TRIM25 as a Negative Regulator of Caspase-2 Expression Reveals a Novel Target for Sensitizing Colon Carcinoma Cells to Intrinsic Apoptosis. Cells 2019;8:E1622. [PMID: 31842382 DOI: 10.3390/cells8121622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
209 Li Y, Kong D, Ahmad A, Bao B, Dyson G, Sarkar FH. Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion. Epigenetics 2012;7:940-9. [PMID: 22805767 DOI: 10.4161/epi.21236] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 8.4] [Reference Citation Analysis]
210 Fan W, Liu T, Li X, Zhou Y, Wu M, Cui X, Chen H, Qian P. TRIM52: A nuclear TRIM protein that positively regulates the nuclear factor-kappa B signaling pathway. Mol Immunol 2017;82:114-22. [PMID: 28073078 DOI: 10.1016/j.molimm.2017.01.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
211 Carotenuto M, Pedone E, Diana D, de Antonellis P, Džeroski S, Marino N, Navas L, Di Dato V, Scoppettuolo MN, Cimmino F. Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction. Sci Rep. 2013;3:1351. [PMID: 23448979 DOI: 10.1038/srep01351] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
212 Liu L, Wong CC, Gong B, Yu J. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer. Oncogene 2018;37:148-59. [PMID: 28925398 DOI: 10.1038/onc.2017.313] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
213 Tubbs AT, Dorsett Y, Chan E, Helmink B, Lee BS, Hung P, George R, Bredemeyer AL, Mittal A, Pappu RV, Chowdhury D, Mosammaparast N, Krangel MS, Sleckman BP. KAP-1 promotes resection of broken DNA ends not protected by γ-H2AX and 53BP1 in G₁-phase lymphocytes. Mol Cell Biol 2014;34:2811-21. [PMID: 24842905 DOI: 10.1128/MCB.00441-14] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
214 Mizushima W, Takahashi H, Watanabe M, Kinugawa S, Matsushima S, Takada S, Yokota T, Furihata T, Matsumoto J, Tsuda M, Chiba I, Nagashima S, Yanagi S, Matsumoto M, Nakayama KI, Tsutsui H, Hatakeyama S. The novel heart-specific RING finger protein 207 is involved in energy metabolism in cardiomyocytes. Journal of Molecular and Cellular Cardiology 2016;100:43-53. [DOI: 10.1016/j.yjmcc.2016.09.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
215 Jiang W, Cai X, Xu T, Liu K, Yang D, Fan L, Li G, Yu X. Tripartite Motif-Containing 46 Promotes Viability and Inhibits Apoptosis of Osteosarcoma Cells by Activating NF-B Signaling Through Ubiquitination of PPAR. Oncol Res 2020;28:409-21. [PMID: 32295675 DOI: 10.3727/096504020X15868639303417] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
216 Dükel M, Streitfeld WS, Tang TC, Backman LR, Ai L, May WS, Brown KD. The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia. J Biol Chem 2016;291:21541-52. [PMID: 27535224 DOI: 10.1074/jbc.M116.730960] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
217 Zhang G, Smith SG, Zhou MM. Discovery of Chemical Inhibitors of Human Bromodomains. Chem Rev 2015;115:11625-68. [PMID: 26492937 DOI: 10.1021/acs.chemrev.5b00205] [Cited by in Crossref: 75] [Cited by in F6Publishing: 60] [Article Influence: 12.5] [Reference Citation Analysis]
218 Wang K Master’s degree, Chen Z Master’s degree, Long L Master’s degree, Tao Y Master’s degree, Wu Q Master’s degree, Xiang M Master’s degree, Liang Y Bachelor’s degree, Xie X Bachelor’s degree, Jiang Y Master’s degree, Xiao Z Doctor’s degree, Yan Y, Qiu S Bachelor’s degree, Yi B Doctor’s degree. iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma. Cancer Biol Ther 2018;19:809-24. [PMID: 30067426 DOI: 10.1080/15384047.2018.1472192] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
219 Pan S, Deng Y, Fu J, Zhang Y, Zhang Z, Ru X, Qin X. TRIM52 promotes colorectal cancer cell proliferation through the STAT3 signaling. Cancer Cell Int 2019;19:57. [PMID: 30918473 DOI: 10.1186/s12935-019-0775-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
220 He R, Liu H. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2. Gene 2020;747:144553. [PMID: 32165307 DOI: 10.1016/j.gene.2020.144553] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
221 Saito-Kanatani M, Urano T, Hiroi H, Momoeda M, Ito M, Fujii T, Inoue S. Identification of TRIM22 as a progesterone-responsive gene in Ishikawa endometrial cancer cells. J Steroid Biochem Mol Biol 2015;154:217-25. [PMID: 26316153 DOI: 10.1016/j.jsbmb.2015.08.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
222 Su X, Wang J, Chen W, Li Z, Fu X, Yang A. Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway. Oncotarget 2016;7:9939-50. [PMID: 26799420 DOI: 10.18632/oncotarget.6941] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
223 An Y, Ni Y, Xu Z, Shi S, He J, Liu Y, Deng KY, Fu M, Jiang M, Xin HB. TRIM59 expression is regulated by Sp1 and Nrf1 in LPS-activated macrophages through JNK signaling pathway. Cell Signal 2020;67:109522. [PMID: 31883458 DOI: 10.1016/j.cellsig.2019.109522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
224 Prescott JD, Zeiger MA. The RET oncogene in papillary thyroid carcinoma: RET Mutations in Papillary Thyroid Ca. Cancer 2015;121:2137-46. [DOI: 10.1002/cncr.29044] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
225 Zhu Z, Wang Y, Zhang C, Yu S, Zhu Q, Hou K, Yan B. TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-β signaling. Sci Rep 2016;6:19070. [PMID: 26754079 DOI: 10.1038/srep19070] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
226 Mattoscio D, Chiocca S. SUMO pathway components as possible cancer biomarkers. Future Oncol. 2015;11:1599-1610. [PMID: 26043214 DOI: 10.2217/fon.15.41] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
227 Wang M, Chao C, Luo G, Wang B, Zhan X, Di D, Qian Y, Zhang X. Prognostic significance of TRIM59 for cancer patient survival: A systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e18024. [PMID: 31770215 DOI: 10.1097/MD.0000000000018024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
228 Liu TY, Chen J, Shang CL, Shen HW, Huang JM, Liang YC, Wang W, Zhao YH, Liu D, Shu M, Guo LY, Hu Z, Yao SZ. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer. J Exp Clin Cancer Res 2016;35:170. [PMID: 27793172 DOI: 10.1186/s13046-016-0445-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
229 Zeng F, Wang K, Liu X, Zhao Z. Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma. Cell Commun Signal 2020;18:2. [PMID: 31907037 DOI: 10.1186/s12964-019-0492-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
230 Lyu L, Chen Z, McCarty N. TRIM44 links the UPS to SQSTM1/p62-dependent aggrephagy and removing misfolded proteins. Autophagy 2021;:1-16. [PMID: 34382902 DOI: 10.1080/15548627.2021.1956105] [Reference Citation Analysis]
231 Fan Y, Peng X, Li B, Zhao G. Development of Autophagy Signature-Based Prognostic Nomogram for Refined Glioma Survival Prognostication. Biomed Res Int 2020;2020:1872962. [PMID: 32964017 DOI: 10.1155/2020/1872962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
232 Lee HJ. The Role of Tripartite Motif Family Proteins in TGF-β Signaling Pathway and Cancer. J Cancer Prev 2018;23:162-9. [PMID: 30671398 DOI: 10.15430/JCP.2018.23.4.162] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
233 Qi Z, Cai S, Cai J, Chen L, Yao Y, Chen L, Mao Y. miR-491 regulates glioma cells proliferation by targeting TRIM28 in vitro. BMC Neurol 2016;16:248. [PMID: 27905892 DOI: 10.1186/s12883-016-0769-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
234 Gallouet AS, Ferri F, Petit V, Parcelier A, Lewandowski D, Gault N, Barroca V, Le Gras S, Soler E, Grosveld F, Davidson I, Romeo PH. Macrophage production and activation are dependent on TRIM33. Oncotarget 2017;8:5111-22. [PMID: 27974684 DOI: 10.18632/oncotarget.13872] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
235 Liu K, Zhang C, Li B, Xie W, Zhang J, Nie X, Tan P, Zheng L, Wu S, Qin Y, Cui J, Zhi F. Mutual Stabilization between TRIM9 Short Isoform and MKK6 Potentiates p38 Signaling to Synergistically Suppress Glioblastoma Progression. Cell Rep 2018;23:838-51. [PMID: 29669288 DOI: 10.1016/j.celrep.2018.03.096] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
236 Liu GM, Zhang YM. Targeting FBPase is an emerging novel approach for cancer therapy. Cancer Cell Int 2018;18:36. [PMID: 29556139 DOI: 10.1186/s12935-018-0533-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
237 Yu YP, Cai LC, Wang XY, Cheng SY, Zhang DM, Jian WG, Wang TD, Yang JK, Yang KB, Zhang C. BMP8A promotes survival and drug resistance via Nrf2/TRIM24 signaling pathway in clear cell renal cell carcinoma. Cancer Sci 2020;111:1555-66. [PMID: 32128917 DOI: 10.1111/cas.14376] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
238 Song Y, Meng L, Yu J, Cao Z, Sun J, Zhao H. TRIM66 Overexpression Promotes Glioma Progression and Regulates Glucose Uptake Through cMyc/GLUT3 Signaling. Cancer Manag Res 2021;13:5187-201. [PMID: 34234562 DOI: 10.2147/CMAR.S293728] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Alomari M. TRIM21 - A potential novel therapeutic target in cancer. Pharmacol Res 2021;165:105443. [PMID: 33508433 DOI: 10.1016/j.phrs.2021.105443] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Hao L, Wang JM, Liu BQ, Yan J, Li C, Jiang JY, Zhao FY, Qiao HY, Wang HQ. m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells. Biochim Biophys Acta Mol Cell Res 2021;1868:118878. [PMID: 33011193 DOI: 10.1016/j.bbamcr.2020.118878] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
241 Xia Y, Zhao J, Yang C. Identification of key genes and pathways for melanoma in the TRIM family. Cancer Med 2020;9:8989-9005. [PMID: 33118318 DOI: 10.1002/cam4.3545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
242 Fu H, Yang H, Zhang X, Wang B, Mao J, Li X, Wang M, Zhang B, Sun Z, Qian H, Xu W. Exosomal TRIM3 is a novel marker and therapy target for gastric cancer. J Exp Clin Cancer Res. 2018;37:162. [PMID: 30031392 DOI: 10.1186/s13046-018-0825-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
243 Pathiraja TN, Thakkar KN, Jiang S, Stratton S, Liu Z, Gagea M, Shi X, Shah PK, Phan L, Lee MH, Andersen J, Stampfer M, Barton MC. TRIM24 links glucose metabolism with transformation of human mammary epithelial cells. Oncogene 2015;34:2836-45. [PMID: 25065590 DOI: 10.1038/onc.2014.220] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
244 Han Y, Tian H, Chen P, Lin Q. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma. Oncotarget 2017;8:22730-40. [PMID: 28186994 DOI: 10.18632/oncotarget.15188] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
245 Wang X, Zhang H, Shao Z, Zhuang W, Sui C, Liu F, Chen X, Hou J, Kong L, Liu H, Zheng Y, Liu B, Chen T, Zhang L, Jia X, Gao C. TRIM31 facilitates K27-linked polyubiquitination of SYK to regulate antifungal immunity. Signal Transduct Target Ther 2021;6:298. [PMID: 34362877 DOI: 10.1038/s41392-021-00711-3] [Reference Citation Analysis]
246 Horie-inoue K. TRIM proteins as trim tabs for the homoeostasis. Journal of Biochemistry 2013;154:309-12. [DOI: 10.1093/jb/mvt076] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
247 Kim Y, Song KS, Sohn EH, Kang SW, Yoo IS, Shim S, Yoo S, Kim J. Anti-TIF1γ antibody and the expression of TIF1γ in idiopathic inflammatory myopathies: XXXX. Int J Rheum Dis 2019;22:314-20. [DOI: 10.1111/1756-185x.13424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
248 Zhang H, Deng Y, Liang L, Shen L, Zhu J, Wang Y, Zhang J, Zhang Z. Knockdown Of TRIM31 Enhances Colorectal Cancer Radiosensitivity By Inducing DNA Damage And Activating Apoptosis. Onco Targets Ther 2019;12:8179-88. [PMID: 31632068 DOI: 10.2147/OTT.S215769] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
249 Wang Z, Tong D, Han C, Zhao Z, Wang X, Jiang T, Li Q, Liu S, Chen L, Chen Y, Li A, Huang C. Blockade of miR-3614 maturation by IGF2BP3 increases TRIM25 expression and promotes breast cancer cell proliferation. EBioMedicine. 2019;41:357-369. [PMID: 30797711 DOI: 10.1016/j.ebiom.2018.12.061] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
250 Zhang LH, Yin AA, Cheng JX, Huang HY, Li XM, Zhang YQ, Han N, Zhang X. TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway. Oncogene 2015;34:600-10. [PMID: 24469053 DOI: 10.1038/onc.2013.593] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 10.0] [Reference Citation Analysis]
251 Kwon SC, Yi H, Eichelbaum K, Föhr S, Fischer B, You KT, Castello A, Krijgsveld J, Hentze MW, Kim VN. The RNA-binding protein repertoire of embryonic stem cells. Nat Struct Mol Biol 2013;20:1122-30. [PMID: 23912277 DOI: 10.1038/nsmb.2638] [Cited by in Crossref: 312] [Cited by in F6Publishing: 272] [Article Influence: 39.0] [Reference Citation Analysis]
252 Sun Q, Fan J, Billiar TR, Scott MJ. Inflammasome and autophagy regulation - a two-way street. Mol Med 2017;23:188-95. [PMID: 28741645 DOI: 10.2119/molmed.2017.00077] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 19.0] [Reference Citation Analysis]
253 Chauhan S, Kumar S, Jain A, Ponpuak M, Mudd MH, Kimura T, Choi SW, Peters R, Mandell M, Bruun JA, Johansen T, Deretic V. TRIMs and Galectins Globally Cooperate and TRIM16 and Galectin-3 Co-direct Autophagy in Endomembrane Damage Homeostasis. Dev Cell 2016;39:13-27. [PMID: 27693506 DOI: 10.1016/j.devcel.2016.08.003] [Cited by in Crossref: 185] [Cited by in F6Publishing: 150] [Article Influence: 37.0] [Reference Citation Analysis]
254 Rong X, Rao J, Li D, Jing Q, Lu Y, Ji Y. TRIM69 inhibits cataractogenesis by negatively regulating p53. Redox Biol 2019;22:101157. [PMID: 30844644 DOI: 10.1016/j.redox.2019.101157] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
255 Zhu G, Harischandra DS, Ghaisas S, Zhang P, Prall W, Huang L, Maghames C, Guo L, Luna E, Mack KL, Torrente MP, Luk KC, Shorter J, Yang X. TRIM11 Prevents and Reverses Protein Aggregation and Rescues a Mouse Model of Parkinson's Disease. Cell Rep 2020;33:108418. [PMID: 33264628 DOI: 10.1016/j.celrep.2020.108418] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
256 Jiang J, Ren H, Xu Y, Wudu M, Wang Q, Liu Z, Su H, Jiang X, Zhang Y, Zhang B, Qiu X. TRIM67 Promotes the Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Positively Regulating the Notch Pathway. J Cancer 2020;11:1240-9. [PMID: 31956370 DOI: 10.7150/jca.38286] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
257 Taniue K, Akimitsu N. Aberrant phase separation and cancer. FEBS J 2021. [PMID: 33583140 DOI: 10.1111/febs.15765] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
258 Suzuki M, Watanabe M, Nakamaru Y, Takagi D, Takahashi H, Fukuda S, Hatakeyama S. TRIM39 negatively regulates the NFκB-mediated signaling pathway through stabilization of Cactin. Cell Mol Life Sci 2016;73:1085-101. [DOI: 10.1007/s00018-015-2040-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
259 Chen Z, Lin TC, Bi X, Lu G, Dawson BC, Miranda R, Medeiros LJ, McNiece I, McCarty N. TRIM44 promotes quiescent multiple myeloma cell occupancy and survival in the osteoblastic niche via HIF-1α stabilization. Leukemia 2019;33:469-86. [PMID: 30089913 DOI: 10.1038/s41375-018-0222-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
260 Zhou W, Bao S. PML-mediated signaling and its role in cancer stem cells. Oncogene 2014;33:1475-84. [PMID: 23563177 DOI: 10.1038/onc.2013.111] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
261 Drilon A, Hu ZI, Lai GGY, Tan DSW. Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes. Nat Rev Clin Oncol 2018;15:151-67. [PMID: 29134959 DOI: 10.1038/nrclinonc.2017.175] [Cited by in Crossref: 98] [Cited by in F6Publishing: 80] [Article Influence: 24.5] [Reference Citation Analysis]
262 Xu L, Wu Q, Zhou X, Wu Q, Fang M. TRIM13 inhibited cell proliferation and induced cell apoptosis by regulating NF-κB pathway in non-small-cell lung carcinoma cells. Gene 2019;715:144015. [PMID: 31357025 DOI: 10.1016/j.gene.2019.144015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
263 De Cesare V, Johnson C, Barlow V, Hastie J, Knebel A, Trost M. The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway. Cell Chem Biol 2018;25:1117-1127.e4. [PMID: 30017913 DOI: 10.1016/j.chembiol.2018.06.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 9.7] [Reference Citation Analysis]
264 Love IM, Grossman SR. It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53. Genes Cancer. 2012;3:249-263. [PMID: 23150758 DOI: 10.1177/1947601912455198] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
265 Li K, Pan W, Ma Y, Xu X, Gao Y, He Y, Wei L, Zhang J. A novel oncogene TRIM63 promotes cell proliferation and migration via activating Wnt/β-catenin signaling pathway in breast cancer. Pathol Res Pract 2019;215:152573. [PMID: 31399258 DOI: 10.1016/j.prp.2019.152573] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
266 Zhang C, Mukherjee S, Tucker-Burden C, Ross JL, Chau MJ, Kong J, Brat DJ. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3. Mol Oncol 2017;11:280-94. [PMID: 28100038 DOI: 10.1002/1878-0261.12034] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
267 Jiang J, Liu D, Xu G, Liang T, Yu C, Liao S, Chen L, Huang S, Sun X, Yi M, Zhang Z, Lu Z, Wang Z, Chen J, Chen T, Li H, Yao Y, Chen W, Guo H, Liu C, Zhan X. TRIM68, PIKFYVE, and DYNLL2: The Possible Novel Autophagy- and Immunity-Associated Gene Biomarkers for Osteosarcoma Prognosis. Front Oncol 2021;11:643104. [PMID: 33968741 DOI: 10.3389/fonc.2021.643104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
268 Wang Y, Ren F, Wang Y, Feng Y, Wang D, Jia B, Qiu Y, Wang S, Yu J, Sung JJ. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer. Carcinogenesis. 2014;35:983-991. [PMID: 24302614 DOI: 10.1093/carcin/bgt393] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 7.0] [Reference Citation Analysis]
269 Groner AC, Cato L, de Tribolet-Hardy J, Bernasocchi T, Janouskova H, Melchers D, Houtman R, Cato ACB, Tschopp P, Gu L, Corsinotti A, Zhong Q, Fankhauser C, Fritz C, Poyet C, Wagner U, Guo T, Aebersold R, Garraway LA, Wild PJ, Theurillat JP, Brown M. TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer. Cancer Cell 2016;29:846-58. [PMID: 27238081 DOI: 10.1016/j.ccell.2016.04.012] [Cited by in Crossref: 118] [Cited by in F6Publishing: 106] [Article Influence: 23.6] [Reference Citation Analysis]
270 Wei WS, Chen X, Guo LY, Li XD, Deng MH, Yuan GJ, He LY, Li YH, Zhang ZL, Jiang LJ, Chen RX, Ma XD, Wei S, Ma NF, Liu ZW, Luo JH, Zhou FJ, Xie D. TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation. Cancer Lett. 2018;435:10-22. [PMID: 30075204 DOI: 10.1016/j.canlet.2018.07.036] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
271 Sutton SK, Cheung BB, Massudi H, Tan O, Koach J, Mayoh C, Carter DR, Marshall GM. Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis. J Cancer Res Clin Oncol 2019;145:2241-50. [PMID: 31342168 DOI: 10.1007/s00432-019-02981-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
272 Ramachandran H, Schäfer T, Kim Y, Herfurth K, Hoff S, Lienkamp SS, Kramer-Zucker A, Walz G. Interaction with the Bardet-Biedl gene product TRIM32/BBS11 modifies the half-life and localization of Glis2/NPHP7. J Biol Chem 2014;289:8390-401. [PMID: 24500717 DOI: 10.1074/jbc.M113.534024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
273 Di K, Linskey ME, Bota DA. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth. Oncogene 2013;32:5038-47. [PMID: 23178488 DOI: 10.1038/onc.2012.531] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
274 Yang T, Li M, Li H, Shi P, Liu J, Chen M. Downregulation of circEPSTI1 represses the proliferation and invasion of non-small cell lung cancer by inhibiting TRIM24 via miR-1248 upregulation. Biochem Biophys Res Commun 2020;530:348-54. [PMID: 32828310 DOI: 10.1016/j.bbrc.2020.06.106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
275 Xu G, Guo Y, Xu D, Wang Y, Shen Y, Wang F, Lv Y, Song F, Jiang D, Zhang Y, Lou Y, Meng Y, Yang Y, Kang Y. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway. Sci Rep 2017;7:42411. [PMID: 28205534 DOI: 10.1038/srep42411] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
276 Xing Y, Meng Q, Chen X, Zhao Y, Liu W, Hu J, Xue F, Wang X, Cai L. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway. Oncotarget 2016;7:30479-91. [PMID: 27058415 DOI: 10.18632/oncotarget.8586] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
277 Veliz I, Loo Y, Castillo O, Karachaliou N, Nigro O, Rosell R. Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future? Ann Transl Med 2015;3:7. [PMID: 25705639 DOI: 10.3978/j.issn.2305-5839.2014.10.06] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
278 Wang J, Zhu J, Dong M, Yu H, Dai X, Li K. Knockdown of tripartite motif containing 24 by lentivirus suppresses cell growth and induces apoptosis in human colorectal cancer cells. Oncol Res 2014;22:39-45. [PMID: 25700357 DOI: 10.3727/096504014X14078436005012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
279 D Antonio M, Weghorn D, D Antonio-Chronowska A, Coulet F, Olson KM, DeBoever C, Drees F, Arias A, Alakus H, Richardson AL, Schwab RB, Farley EK, Sunyaev SR, Frazer KA. Identifying DNase I hypersensitive sites as driver distal regulatory elements in breast cancer. Nat Commun 2017;8:436. [PMID: 28874753 DOI: 10.1038/s41467-017-00100-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
280 Sutton SK, Carter DR, Kim P, Tan O, Arndt GM, Zhang XD, Baell J, Noll BD, Wang S, Kumar N, McArthur GA, Cheung BB, Marshall GM. A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner. Oncotarget 2016;7:52166-78. [PMID: 27447557 DOI: 10.18632/oncotarget.10700] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
281 Wang F, Wang H, Sun L, Niu C, Xu J. TRIM59 inhibits PPM1A through ubiquitination and activates TGF-β/Smad signaling to promote the invasion of ectopic endometrial stromal cells in endometriosis. Am J Physiol Cell Physiol 2020;319:C392-401. [PMID: 32348176 DOI: 10.1152/ajpcell.00127.2019] [Reference Citation Analysis]
282 Xie H, Yan Z, Feng S, Zhu T, Zhu Z, Ni J, Ni J, Du R, Zhu J, Ding F, Liu S, Han H, Zhang H, Zhao J, Zhang R, Quan W, Yan X. Prognostic Value of Circulating MG53 Levels in Acute Myocardial Infarction. Front Cardiovasc Med 2020;7:596107. [PMID: 33195485 DOI: 10.3389/fcvm.2020.596107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
283 Palmer WS. Development of small molecule inhibitors of BRPF1 and TRIM24 bromodomains. Drug Discovery Today: Technologies 2016;19:65-71. [DOI: 10.1016/j.ddtec.2016.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
284 Yang Z, Wu XS, Wei Y, Polyanskaya SA, Iyer SV, Jung M, Lach FP, Adelman ER, Klingbeil O, Milazzo JP, Kramer M, Demerdash OE, Chang K, Goodwin S, Hodges E, McCombie WR, Figueroa ME, Smogorzewska A, Vakoc CR. Transcriptional Silencing of ALDH2 Confers a Dependency on Fanconi Anemia Proteins in Acute Myeloid Leukemia. Cancer Discov 2021;11:2300-15. [PMID: 33893150 DOI: 10.1158/2159-8290.CD-20-1542] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
285 Jiang S, Minter LC, Stratton SA, Yang P, Abbas HA, Akdemir ZC, Pant V, Post S, Gagea M, Lee RG. TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice. J Hepatol. 2015;62:371-379. [PMID: 25281858 DOI: 10.1016/j.jhep.2014.09.026] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 5.9] [Reference Citation Analysis]
286 Zottel A, Jovčevska I, Šamec N, Mlakar J, Šribar J, Križaj I, Skoblar Vidmar M, Komel R. Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration. Ther Adv Med Oncol 2020;12:1758835920915302. [PMID: 32426045 DOI: 10.1177/1758835920915302] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
287 Hu X, Tang Z, Ma S, Yu Y, Chen X, Zang G. Tripartite motif-containing protein 7 regulates hepatocellular carcinoma cell proliferation via the DUSP6/p38 pathway. Biochemical and Biophysical Research Communications 2019;511:889-95. [DOI: 10.1016/j.bbrc.2019.02.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
288 Qi L, Lu Z, Sun YH, Song HT, Xu WK. TRIM16 suppresses the progression of prostate tumors by inhibiting the Snail signaling pathway. Int J Mol Med 2016;38:1734-42. [PMID: 27748839 DOI: 10.3892/ijmm.2016.2774] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
289 Fang Z, Deng J, Zhang L, Xiang X, Yu F, Chen J, Feng M, Xiong J. TRIM24 promotes the aggression of gastric cancer via the Wnt/β-catenin signaling pathway. Oncol Lett 2017;13:1797-806. [PMID: 28454326 DOI: 10.3892/ol.2017.5604] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
290 Nenasheva VV, Nikitenko NA, Stepanenko EA, Makarova IV, Andreeva LE, Kovaleva GV, Lysenko AA, Tukhvatulin AI, Logunov DY, Tarantul VZ. Human TRIM14 protects transgenic mice from influenza A viral infection without activation of other innate immunity pathways. Genes Immun 2021;22:56-63. [PMID: 33864033 DOI: 10.1038/s41435-021-00128-6] [Reference Citation Analysis]
291 Tan H, Qi J, Chu G, Liu Z. Tripartite Motif 16 Inhibits the Migration and Invasion in Ovarian Cancer Cells. Oncol Res 2017;25:551-8. [PMID: 27737724 DOI: 10.3727/096504016X14758370595285] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
292 Zhou Y, Wang B, Wang Y, Chen G, Lian Q, Wang H. miR-140-3p inhibits breast cancer proliferation and migration by directly regulating the expression of tripartite motif 28. Oncol Lett 2019;17:3835-41. [PMID: 30881504 DOI: 10.3892/ol.2019.10038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
293 Meroni G. TRIM E3 Ubiquitin Ligases in Rare Genetic Disorders. Adv Exp Med Biol 2020;1233:311-25. [PMID: 32274764 DOI: 10.1007/978-3-030-38266-7_14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
294 Cai F, Cai L, Zhou Z, Pan X, Wang M, Chen S, Luis MAF, Cen C, Biskup E. Prognostic role of Tif1γ expression and circulating tumor cells in patients with breast cancer. Mol Med Rep 2019;19:3685-95. [PMID: 30896800 DOI: 10.3892/mmr.2019.10033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
295 Piao MY, Cao HL, He NN, Xu MQ, Dong WX, Wang WQ, Wang BM, Zhou B. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development. Scand J Gastroenterol 2016;51:572-82. [PMID: 26691157 DOI: 10.3109/00365521.2015.1124285] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
296 Xiang Y, Zhang S, Lu J, Zhang W, Cai M, Xiang J, Cai D. Ginkgolide B protects human pulmonary alveolar epithelial A549 cells from lipopolysaccharide-induced inflammatory responses by reducing TRIM37-mediated NF-κB activation. Biotechnol Appl Biochem 2020;67:903-11. [PMID: 31691373 DOI: 10.1002/bab.1847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
297 Petit V, Parcelier A, Mathé C, Barroca V, Torres C, Lewandowski D, Ferri F, Gallouët AS, Dalloz M, Dinet O, Boschetti G, Vozenin MC, Roméo PH. TRIM33 deficiency in monocytes and macrophages impairs resolution of colonic inflammation. EBioMedicine 2019;44:60-70. [PMID: 31130476 DOI: 10.1016/j.ebiom.2019.05.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
298 Wu T, Zhang DL, Wang JM, Jiang JY, Du X, Zeng XY, Du ZX. TRIM29 inhibits miR-873-5P biogenesis via CYTOR to upregulate fibronectin 1 and promotes invasion of papillary thyroid cancer cells. Cell Death Dis 2020;11:813. [PMID: 32994394 DOI: 10.1038/s41419-020-03018-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
299 Zhou C, Zhang Z, Zhu X, Qian G, Zhou Y, Sun Y, Yu W, Wang J, Lu H, Lin F, Shen Z, Zheng S. N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1. EBioMedicine 2020;59:102955. [PMID: 32853985 DOI: 10.1016/j.ebiom.2020.102955] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
300 Koliopoulos MG, Esposito D, Christodoulou E, Taylor IA, Rittinger K. Functional role of TRIM E3 ligase oligomerization and regulation of catalytic activity. EMBO J 2016;35:1204-18. [PMID: 27154206 DOI: 10.15252/embj.201593741] [Cited by in Crossref: 94] [Cited by in F6Publishing: 82] [Article Influence: 18.8] [Reference Citation Analysis]
301 Massagué J, Xi Q. TGF-β control of stem cell differentiation genes. FEBS Lett. 2012;586:1953-1958. [PMID: 22710171 DOI: 10.1016/j.febslet.2012.03.023] [Cited by in Crossref: 107] [Cited by in F6Publishing: 89] [Article Influence: 11.9] [Reference Citation Analysis]
302 Liang C, Dong H, Miao C, Zhu J, Wang J, Li P, Li J, Wang Z. TRIM29 as a prognostic predictor for multiple human malignant neoplasms: a systematic review and meta-analysis. Oncotarget 2018;9:12323-32. [PMID: 29552313 DOI: 10.18632/oncotarget.23617] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
303 Watanabe M, Saeki Y, Takahashi H, Ohtake F, Yoshida Y, Kasuga Y, Kondo T, Yaguchi H, Suzuki M, Ishida H, Tanaka K, Hatakeyama S. A substrate-trapping strategy to find E3 ubiquitin ligase substrates identifies Parkin and TRIM28 targets. Commun Biol 2020;3:592. [PMID: 33082525 DOI: 10.1038/s42003-020-01328-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
304 Gao B, Xu W, Zhong L, Zhang Q, Su Y, Xiong S. p300, but not PCAF, collaborates with IRF-1 in stimulating TRIM22 expression independently of its histone acetyltransferase activity. Eur J Immunol 2013;43:2174-84. [PMID: 23670564 DOI: 10.1002/eji.201343308] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
305 Zhou Z, Liu Y, Ma M, Chang L. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway. Biomedicine & Pharmacotherapy 2017;96:98-103. [DOI: 10.1016/j.biopha.2017.09.132] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
306 Malchenko S, Sredni ST, Boyineni J, Bi Y, Margaryan NV, Guda MR, Kostenko Y, Tomita T, Davuluri RV, Velpula K, Hendrix MJC, Soares MB. Characterization of brain tumor initiating cells isolated from an animal model of CNS primitive neuroectodermal tumors. Oncotarget 2018;9:13733-47. [PMID: 29568390 DOI: 10.18632/oncotarget.24460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
307 Liu R, Li H, Xu Y, Li X, Guo X, Shi J, Cui Y, Wang Z, Liu J. Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53. Oncol Lett 2021;21:6. [PMID: 33240412 DOI: 10.3892/ol.2020.12267] [Reference Citation Analysis]
308 Tian Y, Jin Z, Zhu P, Liu S, Zhang D, Tang M, Wang Y, Li D, Yan D, Li G, Zhu X. TRIM59: A membrane protein expressed on Bacillus Calmette-Guérin-activated macrophages that induces apoptosis of fibrosarcoma cells by direct contact. Experimental Cell Research 2019;384:111590. [DOI: 10.1016/j.yexcr.2019.111590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
309 Yang G, Liang Y, Zheng T, Song R, Wang J, Shi H, Sun B, Xie C, Li Y, Han J, Pan S, Lan Y, Liu X, Zhu M, Wang Y, Liu L. FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling. Cancer Lett 2016;378:80-6. [PMID: 27177473 DOI: 10.1016/j.canlet.2016.05.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
310 Bang S, Kaur S, Kurokawa M. Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway. Int J Mol Sci 2019;21:E261. [PMID: 31905981 DOI: 10.3390/ijms21010261] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
311 Chen Y, Li L, Qian X, Ge Y, Xu G. High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 2017;41:190-6. [PMID: 28065743 DOI: 10.1016/j.clinre.2016.09.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
312 Xiao G, Yang Q, Bao Z, Mao H, Zhang Y, Lin S. Expression of tripartite motif-containing 44 and its prognostic and clinicopathological value in human malignancies:a meta-analysis. BMC Cancer 2020;20:525. [PMID: 32503466 DOI: 10.1186/s12885-020-07014-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
313 Zhang S, Guo JT, Wu JZ, Yang G. Identification and characterization of multiple TRIM proteins that inhibit hepatitis B virus transcription. PLoS One 2013;8:e70001. [PMID: 23936368 DOI: 10.1371/journal.pone.0070001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
314 Guo Y, Wei X, Das J, Grimson A, Lipkin SM, Clark AG, Yu H. Dissecting disease inheritance modes in a three-dimensional protein network challenges the "guilt-by-association" principle. Am J Hum Genet 2013;93:78-89. [PMID: 23791107 DOI: 10.1016/j.ajhg.2013.05.022] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
315 Kimura N, Yamada Y, Takayama KI, Fujimura T, Takahashi S, Kume H, Inoue S. Androgen-responsive tripartite motif 36 enhances tumor-suppressive effect by regulating apoptosis-related pathway in prostate cancer. Cancer Sci 2018;109:3840-52. [PMID: 30238687 DOI: 10.1111/cas.13803] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
316 Gao B, Wang Y, Xu W, Li S, Li Q, Xiong S. Inhibition of Histone Deacetylase Activity Suppresses IFN-γ Induction of Tripartite Motif 22 via CHIP-Mediated Proteasomal Degradation of IRF-1. J I 2013;191:464-71. [DOI: 10.4049/jimmunol.1203533] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
317 Martínez FP, Tang Q. Identification of cellular proteins that interact with human cytomegalovirus immediate-early protein 1 by protein array assay. Viruses 2013;6:89-105. [PMID: 24385082 DOI: 10.3390/v6010089] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
318 Xing J, Zhang A, Minze LJ, Li XC, Zhang Z. TRIM29 Negatively Regulates the Type I IFN Production in Response to RNA Virus. J Immunol 2018;201:183-92. [PMID: 29769269 DOI: 10.4049/jimmunol.1701569] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
319 Bao C, Li Y, Huan L, Zhang Y, Zhao F, Wang Q, Liang L, Ding J, Liu L, Chen T, Li J, Yao M, Huang S, He X. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α. Sci Signal 2015;8:ra75. [PMID: 26221053 DOI: 10.1126/scisignal.aaa8441] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
320 Chen L, Zhu G, Johns EM, Yang X. TRIM11 activates the proteasome and promotes overall protein degradation by regulating USP14. Nat Commun 2018;9:1223. [PMID: 29581427 DOI: 10.1038/s41467-018-03499-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
321 Chen C, Zhao D, Fang S, Chen Q, Cheng B, Fang X, Shu Q. TRIM22-Mediated Apoptosis is Associated with Bak Oligomerization in Monocytes. Sci Rep 2017;7:39961. [PMID: 28079123 DOI: 10.1038/srep39961] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
322 Gallenkamp D, Gelato KA, Haendler B, Weinmann H. Bromodomains and their pharmacological inhibitors. ChemMedChem 2014;9:438-64. [PMID: 24497428 DOI: 10.1002/cmdc.201300434] [Cited by in Crossref: 89] [Cited by in F6Publishing: 74] [Article Influence: 12.7] [Reference Citation Analysis]
323 Yamada Y, Kimura N, Takayama KI, Sato Y, Suzuki T, Azuma K, Fujimura T, Ikeda K, Kume H, Inoue S. TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma. Cancer Sci 2020;111:881-90. [PMID: 31883420 DOI: 10.1111/cas.14295] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
324 Luo D, Wang Y, Huan X, Huang C, Yang C, Fan H, Xu Z, Yang L. Identification of a synonymous variant in TRIM59 gene for gastric cancer risk in a Chinese population. Oncotarget 2017;8:11507-16. [PMID: 28009992 DOI: 10.18632/oncotarget.14075] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
325 Kang WS, Park JK, Kim YJ, Cho AR, Park HJ, Kim SK, Paik JW, Lee KJ, Na HR, Kim YY, Lim HK, Jeong HG, Kim JW. Association of tripartite motif family-like 2 (TRIML2) polymorphisms with late-onset Alzheimer's disease risk in a Korean population. Neurosci Lett 2016;630:127-31. [PMID: 27471163 DOI: 10.1016/j.neulet.2016.07.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
326 Cao Y, Shi L, Wang M, Hou J, Wei Y, Du C. ATDC contributes to sustaining the growth and invasion of glioma cells through regulating Wnt/β-catenin signaling. Chemico-Biological Interactions 2019;305:148-55. [DOI: 10.1016/j.cbi.2019.03.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
327 Song X, Fu C, Yang X, Sun D, Zhang X, Zhang J. Tripartite motif-containing 29 as a novel biomarker in non-small cell lung cancer. Oncol Lett 2015;10:2283-8. [PMID: 26622835 DOI: 10.3892/ol.2015.3623] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
328 Li YH, Zhong M, Zang HL, Tian XF. Mechanism of TRIM25 mediated ubiquitination of metastasis associated protein (MTA) 1 in normal liver cells. Exp Cell Res 2018;371:250-4. [PMID: 30118695 DOI: 10.1016/j.yexcr.2018.08.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
329 Chen X, Dong C, Law PT, Chan MT, Su Z, Wang S, Wu WK, Xu H. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer. Gynecologic Oncology 2015;139:513-9. [DOI: 10.1016/j.ygyno.2015.10.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
330 Wei CY, Wang L, Zhu MX, Deng XY, Wang DH, Zhang SM, Ying JH, Yuan X, Wang Q, Xuan TF, He AQ, Qi FZ, Gu JY. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4. J Exp Clin Cancer Res 2019;38:137. [PMID: 30922374 DOI: 10.1186/s13046-019-1138-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
331 Li Y, Ma X, Chen Z, Wu H, Wang P, Wu W, Cheng N, Zeng L, Zhang H, Cai X, Chen SJ, Chen Z, Meng G. B1 oligomerization regulates PML nuclear body biogenesis and leukemogenesis. Nat Commun 2019;10:3789. [PMID: 31439836 DOI: 10.1038/s41467-019-11746-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
332 Sulahian R, Chen J, Arany Z, Jadhav U, Peng S, Rustgi AK, Bass AJ, Srivastava A, Hornick JL, Shivdasani RA. SOX15 governs transcription in human stratified epithelia and a subset of esophageal adenocarcinomas. Cell Mol Gastroenterol Hepatol 2015;1:598-609.e6. [PMID: 26516633 DOI: 10.1016/j.jcmgh.2015.07.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
333 Xue J, Chen Y, Wu Y, Wang Z, Zhou A, Zhang S, Lin K, Aldape K, Majumder S, Lu Z, Huang S. Tumour suppressor TRIM33 targets nuclear β-catenin degradation. Nat Commun 2015;6:6156. [PMID: 25639486 DOI: 10.1038/ncomms7156] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 11.8] [Reference Citation Analysis]
334 Pedraza AM, Stephenson AJ. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours. Curr Opin Urol 2018;28:448-53. [PMID: 29979237 DOI: 10.1097/MOU.0000000000000525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
335 Du H, Xu Q, Xiao S, Wu Z, Gong J, Liu C, Ren G, Wu H. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Life Sci 2019;224:1-11. [PMID: 30876939 DOI: 10.1016/j.lfs.2019.03.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
336 Fang Z, Zhang L, Liao Q, Wang Y, Yu F, Feng M, Xiang X, Xiong J. Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer. J Exp Clin Cancer Res 2017;36:17. [PMID: 28114950 DOI: 10.1186/s13046-017-0489-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
337 Pinal-Fernandez I, Ferrer-Fabregas B, Trallero-Araguas E, Balada E, Martínez MA, Milisenda JC, Aparicio-Español G, Labrador-Horrillo M, Garcia-Patos V, Grau-Junyent JM, Selva-O'Callaghan A. Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis. Rheumatology (Oxford) 2018;57:388-96. [PMID: 29149307 DOI: 10.1093/rheumatology/kex413] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 12.7] [Reference Citation Analysis]
338 Ren H, Xu Y, Wang Q, Jiang J, Wudumuli, Hui L, Zhang Q, Zhang X, Wang E, Sun L, Qiu X. E3 ubiquitin ligase tripartite motif-containing 71 promotes the proliferation of non-small cell lung cancer through the inhibitor of kappaB-α/nuclear factor kappaB pathway. Oncotarget 2018;9:10880-90. [PMID: 29541383 DOI: 10.18632/oncotarget.19075] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
339 D'Amico F, Mukhopadhyay R, Ovaa H, Mulder MPC. Targeting TRIM Proteins: A Quest towards Drugging an Emerging Protein Class. Chembiochem 2021;22:2011-31. [PMID: 33482040 DOI: 10.1002/cbic.202000787] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
340 Huang B, Baek SH. Trim13 Potentiates Toll-Like Receptor 2-Mediated Nuclear Factor κB Activation via K29-Linked Polyubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6. Mol Pharmacol 2017;91:307-16. [PMID: 28087809 DOI: 10.1124/mol.116.106716] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
341 Bermisheva MA, Takhirova ZR, Gilyazova IR, Khusnutdinova EK. MicroRNA Biogenesis Pathway Gene Polymorphisms Are Associated with Breast Cancer Risk. Russ J Genet 2018;54:568-75. [DOI: 10.1134/s1022795418040051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
342 Jiang Y, Wang X, Dong C. Molecular mechanisms of T helper 17 cell differentiation: Emerging roles for transcription cofactors. Adv Immunol 2019;144:121-53. [PMID: 31699215 DOI: 10.1016/bs.ai.2019.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
343 Xu J, Li Z, Su Q, Zhao J, Ma J. Suppression of long noncoding RNA LINC00324 restricts cell proliferation and invasion of papillary thyroid carcinoma through downregulation of TRIM29 via upregulating microRNA-195-5p. Aging (Albany NY) 2020;12:26000-11. [PMID: 33318312 DOI: 10.18632/aging.202219] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
344 Virant-Klun I, Stimpfel M. Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer. Sci Rep. 2016;6:34730. [PMID: 27703207 DOI: 10.1038/srep34730] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
345 Chen N, Balasenthil S, Reuther J, Killary AM. DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity. Cancer Res 2014;74:5683-9. [PMID: 25261235 DOI: 10.1158/0008-5472.CAN-14-1171] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
346 Bouché L, Christ CD, Siegel S, Fernández-Montalván AE, Holton SJ, Fedorov O, Ter Laak A, Sugawara T, Stöckigt D, Tallant C, Bennett J, Monteiro O, Díaz-Sáez L, Siejka P, Meier J, Pütter V, Weiske J, Müller S, Huber KVM, Hartung IV, Haendler B. Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains. J Med Chem 2017;60:4002-22. [PMID: 28402630 DOI: 10.1021/acs.jmedchem.7b00306] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
347 Srihari S, Ragan MA. Systematic tracking of dysregulated modules identifies novel genes in cancer. Bioinformatics 2013;29:1553-61. [DOI: 10.1093/bioinformatics/btt191] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
348 Marín I. Origin and diversification of TRIM ubiquitin ligases. PLoS One 2012;7:e50030. [PMID: 23185523 DOI: 10.1371/journal.pone.0050030] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
349 Fiorentini F, Esposito D, Rittinger K. Does it take two to tango? RING domain self-association and activity in TRIM E3 ubiquitin ligases. Biochem Soc Trans 2020;48:2615-24. [PMID: 33170204 DOI: 10.1042/BST20200383] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
350 Chung YL, Wu ML. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis. J Pathol. 2013;230:377-387. [PMID: 23620081 DOI: 10.1002/path.4195] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
351 Chesnokova V, Zonis S, Zhou C, Recouvreux MV, Ben-Shlomo A, Araki T, Barrett R, Workman M, Wawrowsky K, Ljubimov VA, Uhart M, Melmed S. Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A 2016;113:E3250-9. [PMID: 27226307 DOI: 10.1073/pnas.1600561113] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 8.6] [Reference Citation Analysis]
352 Sutton SK, Koach J, Tan O, Liu B, Carter DR, Wilmott JS, Yosufi B, Haydu LE, Mann GJ, Thompson JF, Long GV, Liu T, McArthur G, Zhang XD, Scolyer RA, Cheung BB, Marshall GM. TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells. Oncotarget 2014;5:10127-39. [PMID: 25333256 DOI: 10.18632/oncotarget.2466] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
353 Sun H, Dai X, Han B. TRIM29 as a novel biomarker in pancreatic adenocarcinoma. Dis Markers 2014;2014:317817. [PMID: 24864129 DOI: 10.1155/2014/317817] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
354 Appikonda S, Thakkar KN, Shah PK, Dent SYR, Andersen JN, Barton MC. Cross-talk between chromatin acetylation and SUMOylation of tripartite motif-containing protein 24 (TRIM24) impacts cell adhesion. J Biol Chem 2018;293:7476-85. [PMID: 29523690 DOI: 10.1074/jbc.RA118.002233] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
355 Fu B, Wang L, Ding H, Schwamborn JC, Li S, Dorf ME. TRIM32 Senses and Restricts Influenza A Virus by Ubiquitination of PB1 Polymerase. PLoS Pathog 2015;11:e1004960. [PMID: 26057645 DOI: 10.1371/journal.ppat.1004960] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 14.0] [Reference Citation Analysis]
356 Fan W, Wu M, Qian S, Zhou Y, Chen H, Li X, Qian P. TRIM52 inhibits Japanese Encephalitis Virus replication by degrading the viral NS2A. Sci Rep 2016;6:33698. [PMID: 27667714 DOI: 10.1038/srep33698] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
357 Sun N, Xue Y, Dai T, Li X, Zheng N. Tripartite motif containing 25 promotes proliferation and invasion of colorectal cancer cells through TGF-β signaling. Biosci Rep 2017;37:BSR20170805. [PMID: 28620119 DOI: 10.1042/BSR20170805] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
358 Xu Z, Wu W, Yan H, Hu Y, He Q, Luo P. Regulation of p53 stability as a therapeutic strategy for cancer. Biochem Pharmacol 2021;185:114407. [PMID: 33421376 DOI: 10.1016/j.bcp.2021.114407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
359 Aussy A, Boyer O, Cordel N. Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer. Front Immunol 2017;8:992. [PMID: 28871260 DOI: 10.3389/fimmu.2017.00992] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 7.8] [Reference Citation Analysis]
360 Li F, Liang J, Bai L. MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression. Biomedicine & Pharmacotherapy 2018;103:782-9. [DOI: 10.1016/j.biopha.2018.04.101] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
361 Ji R, Gu Y, Zhang J, Gao C, Gao W, Zang X, Zhao Y. TRIM7 promotes proliferation and migration of vascular smooth muscle cells in atherosclerosis through activating c-Jun/AP-1. IUBMB Life 2020;72:247-58. [PMID: 31625258 DOI: 10.1002/iub.2181] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
362 Chiang C, Gack MU. Post-translational Control of Intracellular Pathogen Sensing Pathways. Trends Immunol 2017;38:39-52. [PMID: 27863906 DOI: 10.1016/j.it.2016.10.008] [Cited by in Crossref: 80] [Cited by in F6Publishing: 66] [Article Influence: 16.0] [Reference Citation Analysis]
363 Wang Y, Fan Y, Huang Y, Du T, Liu Z, Huang D, Wang Y, Wang N, Zhang P. TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2. Cell Signal 2021;85:110064. [PMID: 34146659 DOI: 10.1016/j.cellsig.2021.110064] [Reference Citation Analysis]
364 Sun J, Zhang T, Cheng M, Hong L, Zhang C, Xie M, Sun P, Fan R, Wang Z, Wang L, Zhong J. TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway. J Exp Clin Cancer Res 2019;38:104. [PMID: 30813948 DOI: 10.1186/s13046-019-1098-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
365 Li Y, Deng L, Zhao X, Li B, Ren D, Yu L, Pan H, Gong Q, Song L, Zhou X, Dai T. Tripartite motif-containing 37 (TRIM37) promotes the aggressiveness of non-small-cell lung cancer cells by activating the NF-κB pathway. J Pathol 2018;246:366-78. [PMID: 30043491 DOI: 10.1002/path.5144] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
366 Ding ZY, Jin GN, Wang W, Chen WX, Wu YH, Ai X, Chen L, Zhang WG, Liang HF, Laurence A. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Hepatology. 2014;60:1620-1636. [PMID: 24954480 DOI: 10.1002/hep.27273] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 7.4] [Reference Citation Analysis]
367 Li Y, Wu H, Wu W, Zhuo W, Liu W, Zhang Y, Cheng M, Chen YG, Gao N, Yu H, Wang L, Li W, Yang M. Structural insights into the TRIM family of ubiquitin E3 ligases. Cell Res 2014;24:762-5. [PMID: 24722452 DOI: 10.1038/cr.2014.46] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 10.3] [Reference Citation Analysis]
368 Ferri F, Petit V, Barroca V, Romeo PH. Interplay between FACT subunit SPT16 and TRIM33 can remodel chromatin at macrophage distal regulatory elements. Epigenetics Chromatin 2019;12:46. [PMID: 31331374 DOI: 10.1186/s13072-019-0288-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
369 Teng YC, Shen ZQ, Kao CH, Tsai TF. Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes. World J Gastroenterol 2016;22:300-25. [PMID: 26755878 DOI: 10.3748/wjg.v22.i1.300] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
370 Zhao G, Liu C, Wen X, Luan G, Xie L, Guo X. The translational values of TRIM family in pan-cancers: From functions and mechanisms to clinics. Pharmacol Ther 2021;227:107881. [PMID: 33930453 DOI: 10.1016/j.pharmthera.2021.107881] [Reference Citation Analysis]
371 Agrawal M, Pandey N, Rastogi M, Dogra S, Singh SK. Chikungunya virus modulates the miRNA expression patterns in human synovial fibroblasts. J Med Virol 2020;92:139-48. [PMID: 31483508 DOI: 10.1002/jmv.25588] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
372 Tan P, Ye Y, He L, Xie J, Jing J, Ma G, Pan H, Han L, Han W, Zhou Y. TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10. PLoS Biol 2018;16:e3000051. [PMID: 30408026 DOI: 10.1371/journal.pbio.3000051] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
373 Micale L, Fusco C, Fontana A, Barbano R, Augello B, De Nittis P, Copetti M, Pellico MT, Mandriani B, Cocciadiferro D, Parrella P, Fazio VM, Dimitri LM, D'Angelo V, Novielli C, Larizza L, Daga A, Merla G. TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survival. BMC Cancer 2015;15:470. [PMID: 26077989 DOI: 10.1186/s12885-015-1449-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
374 Versteeg GA, Benke S, García-Sastre A, Rajsbaum R. InTRIMsic immunity: Positive and negative regulation of immune signaling by tripartite motif proteins. Cytokine Growth Factor Rev 2014;25:563-76. [PMID: 25172371 DOI: 10.1016/j.cytogfr.2014.08.001] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 12.0] [Reference Citation Analysis]
375 Zhou Z, Ji Z, Wang Y, Li J, Cao H, Zhu HH, Gao W. TRIM59 Is Up-regulated in Gastric Tumors, Promoting Ubiquitination and Degradation of p53. Gastroenterology 2014;147:1043-54. [DOI: 10.1053/j.gastro.2014.07.021] [Cited by in Crossref: 82] [Cited by in F6Publishing: 85] [Article Influence: 11.7] [Reference Citation Analysis]
376 Katchman BA, Chowell D, Wallstrom G, Vitonis AF, LaBaer J, Cramer DW, Anderson KS. Autoantibody biomarkers for the detection of serous ovarian cancer. Gynecol Oncol 2017;146:129-36. [PMID: 28427776 DOI: 10.1016/j.ygyno.2017.04.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
377 Wang X, Shi W, Shi H, Lu S, Wang K, Sun C, He J, Jin W, Lv X, Zou H, Shu Y. TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells. J Exp Clin Cancer Res 2016;35:100. [PMID: 27329103 DOI: 10.1186/s13046-016-0379-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 7.6] [Reference Citation Analysis]
378 Zhan W, Zhang S. TRIM proteins in lung cancer: Mechanisms, biomarkers and therapeutic targets. Life Sci 2021;268:118985. [PMID: 33412211 DOI: 10.1016/j.lfs.2020.118985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
379 Chen WX, Cheng L, Xu LY, Qian Q, Zhu YL. Bioinformatics analysis of prognostic value of TRIM13 gene in breast cancer. Biosci Rep 2019;39:BSR20190285. [PMID: 30837324 DOI: 10.1042/BSR20190285] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
380 Ying H, Ji L, Xu Z, Fan X, Tong Y, Liu H, Zhao J, Cai X. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B. Cancer Lett 2020;473:13-24. [PMID: 31875525 DOI: 10.1016/j.canlet.2019.12.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
381 Williams SC, Parsons JL. NTH1 Is a New Target for Ubiquitylation-Dependent Regulation by TRIM26 Required for the Cellular Response to Oxidative Stress. Mol Cell Biol 2018;38:e00616-17. [PMID: 29610152 DOI: 10.1128/MCB.00616-17] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
382 Chen Y, Guo Y, Yang H, Shi G, Xu G, Shi J, Yin N, Chen D. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome. Oncotarget 2015;6:23708-19. [PMID: 26247633 DOI: 10.18632/oncotarget.4291] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
383 Lei G, Liu S, Yang X, He C. TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell. Can J Gastroenterol Hepatol 2021;2021:8870907. [PMID: 33824865 DOI: 10.1155/2021/8870907] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
384 Yin J, Kim TH, Park N, Shin D, Choi HI, Cho S, Park JB, Kim JH. TRIM71 suppresses tumorigenesis via modulation of Lin28B-let-7-HMGA2 signaling. Oncotarget 2016;7:79854-68. [PMID: 27821801 DOI: 10.18632/oncotarget.13036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
385 Celen AB, Sahin U. Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts. FEBS J 2020;287:3110-40. [DOI: 10.1111/febs.15319] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 29.0] [Reference Citation Analysis]
386 Guo J, Qin W, Xing Q, Gao M, Wei F, Song Z, Chen L, Lin Y, Gao X, Lin Z. TRIM33 is essential for osteoblast proliferation and differentiation via BMP pathway. J Cell Physiol 2017;232:3158-69. [PMID: 28063228 DOI: 10.1002/jcp.25769] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
387 Bahreyni-Toossi MT, Zafari N, Azimian H, Mehrad-Majd H, Farhadi J, Vaziri Nezamdoust F. Alteration in Expression of Trim29, TRIM37, TRIM44, and β-Catenin Genes After Irradiation in Human Cells with Different Radiosensitivity. Cancer Biother Radiopharm 2020. [PMID: 32833505 DOI: 10.1089/cbr.2020.3915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
388 Vincent DF, Gout J, Chuvin N, Arfi V, Pommier RM, Bertolino P, Jonckheere N, Ripoche D, Kaniewski B, Martel S, Langlois JB, Goddard-Léon S, Colombe A, Janier M, Van Seuningen I, Losson R, Valcourt U, Treilleux I, Dubus P, Bardeesy N, Bartholin L. Tif1γ suppresses murine pancreatic tumoral transformation by a Smad4-independent pathway. Am J Pathol 2012;180:2214-21. [PMID: 22469842 DOI: 10.1016/j.ajpath.2012.02.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
389 Richter J, Ullah K, Xu P, Alscher V, Blatz A, Peifer C, Halekotte J, Leban J, Vitt D, Holzmann K, Bakulev V, Pinna LA, Henne-Bruns D, Hillenbrand A, Kornmann M, Leithäuser F, Bischof J, Knippschild U. Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients. Int J Cancer 2015;136:2799-810. [PMID: 25404202 DOI: 10.1002/ijc.29346] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
390 Yao Y, Liu Z, Cao Y, Guo H, Jiang B, Deng J, Xiong J. Downregulation of TRIM27 suppresses gastric cancer cell proliferation via inhibition of the Hippo-BIRC5 pathway. Pathol Res Pract 2020;216:153048. [PMID: 32825933 DOI: 10.1016/j.prp.2020.153048] [Reference Citation Analysis]
391 Wang M, Wu J, Guo Y, Chang X, Cheng T. The tripartite motif-containing protein 3 on the proliferation and cytokine secretion of rheumatoid arthritis fibroblast-like synoviocytes. Mol Med Rep 2017;15:1607-12. [PMID: 28259936 DOI: 10.3892/mmr.2017.6164] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
392 Winkle CC, McClain LM, Valtschanoff JG, Park CS, Maglione C, Gupton SL. A novel Netrin-1-sensitive mechanism promotes local SNARE-mediated exocytosis during axon branching. J Cell Biol 2014;205:217-32. [PMID: 24778312 DOI: 10.1083/jcb.201311003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 8.4] [Reference Citation Analysis]
393 Sun Q, Ye Z, Qin Y, Fan G, Ji S, Zhuo Q, Xu W, Liu W, Hu Q, Liu M, Zhang Z, Xu X, Yu X. Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2/ITGB7/FAK axis. Oncogene 2020;39:6572-88. [PMID: 32929153 DOI: 10.1038/s41388-020-01452-3] [Reference Citation Analysis]
394 Musselman CA, Kutateladze TG. A histone reader becomes the readout. J Biol Chem 2018;293:7486-7. [PMID: 29752422 DOI: 10.1074/jbc.H118.002881] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
395 Chesnokova V, Zonis S, Barrett R, Kameda H, Wawrowsky K, Ben-Shlomo A, Yamamoto M, Gleeson J, Bresee C, Gorbunova V, Melmed S. Excess growth hormone suppresses DNA damage repair in epithelial cells. JCI Insight 2019;4:125762. [PMID: 30728323 DOI: 10.1172/jci.insight.125762] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
396 Yamada Y, Takayama KI, Fujimura T, Ashikari D, Obinata D, Takahashi S, Ikeda K, Kakutani S, Urano T, Fukuhara H, Homma Y, Inoue S. A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor. Cancer Sci 2017;108:32-41. [PMID: 27754579 DOI: 10.1111/cas.13105] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
397 Sun W, Wang Y, Li D, Wu Y, Ji Q, Sun T. Tripartite motif containing 14: An oncogene in papillary thyroid carcinoma. Biochemical and Biophysical Research Communications 2020;521:360-7. [DOI: 10.1016/j.bbrc.2019.10.127] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
398 Kanno Y, Watanabe M, Kimura T, Nonomura K, Tanaka S, Hatakeyama S. TRIM29 as a novel prostate basal cell marker for diagnosis of prostate cancer. Acta Histochemica 2014;116:708-12. [DOI: 10.1016/j.acthis.2013.12.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]